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ABSTRACT
ELECTROGENERATED CHEMILUMINESCENT STUDIES OF 9,10DIPHENYLANTHRACENE, RUBRENE, TRIS(2,2'-BIPYRIDINE)
RUTHENIUM(II) SPECIES, AND THEIR DERIVATIVES FOR
SENSITIVE DETECTION OF BIOMOLECULES

by Pradip Bastola
August 2017
This dissertation explored and investigated the coreactant electrogenerated
chemiluminescent (ECL) properties of unmixed and mixed systems of highly efficient
ECL emitters, such as 9,10-diphenylanthracene (DPA), rubrene (RUB), and tris(2,2′bipyridine)ruthenium(II) [(Ru(bpy)32+)] species as well as their water-soluble derivatives,
which can serve as ECL labels for sensitive bioanalysis of single or multiple analytes.
The screening of most favorable common ECL coreactants, their concentration effects
along with the effect of working electrode materials on ECL behavior, and energy
transfer related interactions between ECL emitters were systematically investigated. In
addition, a strategy for improvement of ECL signals with the use of nitrate salt as an ECL
enhancing agent was employed. A highly sensitive and selective immunosensor for the
detection of viruses (zika virus or ZIKV and dengue virus or DENV4) has been
developed.
A well-adaptable spectral ECL instrument that can be used for undergraduate
analytical chemistry or instrumental analysis laboratories was first constructed. ECL

ii

coreactant screening studies concluded that benzoyl peroxide (BPO) was the most
suitable coreactant using Pt working electrode.
Water soluble analogues of DPA and RUB, i.e., DPAS and SRUB, were
synthesized and characterized by electrochemical and ECL studies. ECL signals were
enhanced by more than 10 times when a nitrate salt was added to anodic ECL systems. A
nitrate radical was seen using electron paramagnetic resonance (EPR) spectroscopy,
which supported the proposed ECL enhancement mechanism was obtained.
Efforts were made on looking for direct evidence of ECL coreactant intermediates
using EPR spectroscopy. Benzyloxy free radical (C6H5CO2• or BPO•) and sulfate anion
radical (SO4-•) were detected using solid or solution-phase coreactant with or without a
spin trapping agent 5,5-dimethyl-1-pyrroline-N-oxide (DMPO) under UV irradiation or
through chemical reduction reactions.
Finally, zika virus (ZIKV) is a globally emerging mosquito-transmitted flavivirus
that can cause severe fetal abnormalities. Any serotype of dengue virus (DENV1-4)
shows flu like illness. As such, a highly sensitive and specific ECL based immunoassay
was developed for detection of ZIKV and DENV-4 in human biological fluids with an
impressive detection limit of 1 PFU of ZIKV in 100 μL of saline, human plasma, or
human urine.
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CHAPTER I - INTRODUCTION AND BACKGROUND
The essence of this dissertation is to study the electrochemical and
electrogenerated chemiluminescent (ECL) properties of ECL emitters, namely 9,10diphenylanthracene (DPA), rubrene (RUB), and tris(2,2'-bipyridine)ruthenium(II)
complex (Ru(bpy)32+) for their potential applications towards detection and quantification
of biomolecules, such as antigens, viruses, and proteins. Their analysis could be realized
by designing highly efficient ECL based biosensors involving the combination of the
most favorable ECL emitters and coreactants. This chapter briefly reviews various
electroanalytical techniques, ECL and its bio-detection, and spectroscopic methods
associated with ECL studies.
1.1 Electroanalytical Techniques
Electroanalytical techniques are the analytical techniques that study to infer
crucial information, such as concentration and chemical reactivity of the analyte of
interest by measuring electrical responses in the form of e.g., current, charge, oxidation
states, or potential. In other words, these techniques deal with the interaction of electricity
and analyte (usually a chemical species) resulting in chemical change and production of
electrical energy by chemical change. The most common process of carrying out
electrochemical analysis is in an electrochemical cell containing electrodes.1-3 Depending
upon which aspects of the cell are controlled, elctroanalytical techniques are classified as:
(a) potentiometry (potential difference is measured in the absence of current flow), (b)
coulometry (current is measured over time), and (c) voltammetry (current is measured
with varying potential).
1

A wide range of studies employing electroanalytical techniques can be found in
the literature (e.g., scifinder scholar). Recently electroanalytical techniques have been
deployed for analyzing polyphenols in red wine,4 determination of anti HIV drugs,5
identifying lead white pigment,6 analyzing food samples,7-14 pharmaceutical drug
analysis,15-29 probing neurochemical mechanisms and brain chemistry,30-40 understanding
of temperature effects on metal chemodynamics,41 environmental monitoring, 42-45 and
analyzing carcinogenic polycylic aromatic hydrocarbons (PAHs).46
1.1.1 Cyclic voltammetry
Cyclic voltammetry (CV) is a versatile electroanalytical and potentiodynamic
technique, which has been widely used in the understanding of organometallic,47-50
organic,51-55 and polymer chemistry.56-58 CV is a simple and widely employed technique
to obtain qualitative as well as quantitative information of the redox process under
study.59,60 For ferricyanide/ferrocyanide [FeIII(CN)63-]/FeII(CN)64-] system to demonstrate
how this technique can be applied to fundamentally understand the redox process of this
couple. The one electron redox process for ferricyanide/ferrocyanide can be written as:
[FeIII(CN)6]3- + e = [FeII(CN)6]4-

(1.1)

Nernst equation for Equation 1.1 can be expressed as:
[FeIII (CN)3− ]

0
6
𝐸 = 𝐸Fe(CN)
(at 298 K)
3− /Fe(CN)4− + 0.059 log
[FeII (CN)4− ]
6

6

(1.2)

6

where E and E0′ are the measured and formal potentials, respectively. Figure 1.1 shows a
cyclic voltammogram of K3Fe(CN)6 solution. The formal potential can be calculated as:
2

E0′ =

𝐸pa +𝐸pc

(1.3)

2

where Epa and Epc are the anodic and cathodic peak potential, respectively. The separation
of peak potential of a reversible redox process:

∆𝐸p = 𝐸pa − 𝐸pc =

0.057
𝑛

(at 298 K)

(1.4)

where n is the number of electron transfer involved in the redox process. For the process
shown in Equation (1.1) n = 1, thus ΔEp = 57 mV is the expected value.

Epc

iCV(A)

20

10

0

-10

Epa
0.75

0.60

0.45

0.30

0.15

0.00

E (V vs. Ag/AgCl)

Figure 1.1 Cyclic voltammogram (CV) of K3Fe(CN)6.
Note: Cyclic voltammogram was obtained from 6.0 mM K3Fe(CN)6 and 1.0 M KNO3 at a 3.0 mm-diameter glassy carbon working
electrode at a scan rate of 100 mV/s.

For a reversible system, the peak current on the forward scan (ip) is given by the
Randles-Sevcik equation:2,61
3

ip = (2.69×105) n3/2AD1/2Cv1/2

(1.5)

where n is the number of electrons transfer involved, A is the surface area of electrode
(cm2), D is the coefficient of diffusion (cm2/s), C is the concentration of the electroactive
species (mol/cm3), and ν is the scan rate (V/s). Therefore, the magnitude of peak current
is proportional to the concentration of analyte and the square root of scan rate.
CV is often used to check the stability of reaction products, the presence of
intermediates in redox reactions, electron transfer kinetics,62 and the reversibility of a
reaction.63 CV is used to determine the electron stoichiometry of a system,64,65 the
diffusion coefficient of an analyte and the formal reduction potential. Because the
concentration is proportional to current in a reversible nernstian system, concentration of
an unknown analyte can be determined by generating a calibration curve of current vs.
concentration.66,67
1.1.2 Differential pulse voltammetry
Differential pulse voltammetry (DPV) is often the electrochemical technique of
choice when the sensitivity of CV is not enough. In other words, if the redox peaks in CV
are not obvious, one normally considers DPV technique to speculate where the
electroactive species is oxidized or reduced. DPV is none other than the first order
differentiation or derivative of linear sweep voltammetry or staircase voltammetry where
a series of regular voltage pulses applied in a potential linear sweep or stairsteps fashion.
Like all potentiometric methods, the current is measured immediately before each
potential change. A differential pulse voltammogram is a plot of current change of each
4

cycle of pulse vs. potential. During a potential step, the faradaic current decay is much
slower than the charging current decay. Thus, all pulsed techniques could provide much
sensitive and low detection limit results for quantifying an electroactive species as
compared with linear scan or cyclic voltammetry. Figure 1.2 shows a typical potential
waveform of DPV and its voltammogram, where τ is the time of each pulse cycle, tp is the
pulse time, ∆Ep is the pulse potential, and ∆Es is the change in potential per cycle.

Figure 1.2 Potential-excitation signals and voltammogram for DPV (from ref.68).
Note: The current is sampled at the time intervals shown by the black rectangles. ∆i, the current changed is measured by current at
point subtracted from the current at point 2.

1.2 Electrogenerated Chemiluminescence
Electogenerated chemiluminescence (ECL) is a light emission process as a
consequence of electrochemical reaction and is generally potential (voltage) controlled.
The wavelength of the emitted light corresponds to the energy gap between the excited
and ground states of the emitter (luminophore). ECL emitters can be organic, such as
dipyrometheneboron difluoride (BODIPY) as shown in Figure 1.3 (a), inorganic metal
complexes, such as tris(2,2'-bipyridine)osmium(II) [(Os(bpy)32+)] as shown in Figure 1.3
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(b), and semiconductor nanoparticles (quantum dots), such as CdSe/ZnS quantum dots as
shown in Figure 1.3 (c). ECL has been classified into two main categories, namely ion
annihilation ECL and coreactant ECL.

Figure 1.3 Molecular structures of some common ECL emitters
Note: Molecular structures of (a) BODIPY, (b) Os(bpy)32+, and (c) cartoon representation of CdSe (ZnS shell) quantum dot.

1.2.1 Ion annihilation ECL
ECL has been investigated since 1960s as a method of producing light at an
electrode,69 and has been widely used in analyte binding studies.70-72 A typical ECL
process is illustrated in Scheme 1.1, where species A accepts an electron at the cathode to
form a reductive species A-, while species D loses an electron at the anode to form an
oxidative species D+. When both A- and D+ species diffuse from the electrode and meet, a
highly energetic electron transfer process from A- to D+ occurs, resulting in the formation
of the excited state A* that emits light (i.e., ECL emission). The emitted light intensity is
generally proportional to the ECL emitter’s concentration initially present in the solution,
and the emission wavelength reflects the identity of the emitter. Based on the above two
characteristic properties of an ECL system, qualitative and quantitative analysis of a
target analyte associated with an ECL label can be realized. Because both radical anion
6

and cation are produced electrochemically before their annihilation to form ECL, this
type of ECL is called ion annihilation ECL. Note that the chemical species used in ion
annihilation ECL can be the same, for example, A = D = R (i.e., R = 9,10diphenylanthracene (DPA), rubrene (RUB), or tris(2,2'-bipyridine)ruthenium(II)
(Ru(bpy)32+)). After one cycle ion annihilation process, the ECL emitter is regenerated
resulting in high sensitivity of the technique.

Scheme 1.1 Schematic diagram showing general principles of ion annihilation
ECL process.73
Equations (1.6-1.9) list each step of a typical type of ion annihilation ECL.
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R – e → R•+

(oxidation)

(1.6)

R + e → R•−

(reduction)

(1.7)

R•+ + R•− → R + R∗

(ion annihilation)

(1.8)

R∗ → R + hν

(light emission)

(1.9)

Depending on the energy available in an ion annihilation, Equation 1.8, the produced R*
could be either the singlet state species (1R*) or the triplet state species (3R*).
Instead of two working electrodes, in which one is applied with a positive
potential and the other with a negative potential, ion annihilation ECL can also obtained
from an electrochemical system with only one working electrode. In this case, however,
the working electrode must be scanned or pulsed between a positive and a negative
potential alternatively. When R•+ or R•- species is not stable enough for ECL reaction, or
when the ECL solvent has a narrow potential window (e.g., in aqueous solution) so that
R•+ or R•- cannot be formed, no or weak ECL emission can be produced via the ion
annihilation pathway.
The energy available or enthalpy for ion annihilation in Equation 1.8 can be
estimated using modification of the standard Gibbs-Helmholtz equation, G =H - TS
from the redox potential for oxidation and reduction processes in Equations 1.6 and 1.7
using
R

R

−∆𝐻ann = 𝐸p (R•+) − 𝐸p (R•−) − 0.16
8

(1.10)

where −∆𝐻ann is measured in eV. 𝐸p is the peak potential (in volts) for electrochemical
redox process. The numerical value of 0.16 in Equation 1.10 is the entropy approximation
term (TS). If the energy (−∆𝐻ann ) is larger than the energy required for the formation
of lowest excited singlet state and is said to follow “energy sufficient” or S-route,
otherwise it is called “energy deficient system” and follow T-route. If neither route
persists, a third route called ST route arises.
The ion annihilation for S route is summarized as:
R•+ + R•− → R + 1R∗

(singlet excited state formation)

(1.11)

In contrast, the ion-ion annihilation for T route is summarized as:
R•+ + R•− → R + 3R∗

(1.12)

3 ∗

R + 3R∗ → R + 1R∗

(1.13)

9,10-diphenylanthracene (DPA) system, more specifically, DPA•+/DPA•- system
displays the typical S route system,74,75 whereas N,N,N′,N′-tetramethyl-pphenylenediamine/9,10-diphenylanthracene, i.e. TMPD•+/DPA•- generates the excited
state utilizing the T-route.75,76 ST route is usually adopted by RUB•+/RUB•- system.77-80
1.2.2 Coreactant ECL
To overcome the aforementioned problems, coreactant ECL strategies can be
used,72,81,82 in which ECL is generated from a system containing an ECL emitter (e.g.,
Ru(bpy)32+) and a deliberately added substance called coreactant (e.g., tri-n-propylamine
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(TPrA), or benzoyl peroxide (BPO)) upon anodic or cathodic potential scanning or
pulsing. Chemically, a coreactant is a species that, upon electrochemical oxidation or
reduction, immediately undergoes chemical decomposition to form a strongly reducing or
oxidizing intermediate that can react with an oxidized or reduced ECL emitter to generate
excited states. Use of coreactant ECL allows many ECL related studies to be able to
conduct in aqueous media. Depending on the electrode potential scanning direction,
coreactant ECL can be classified as either anodic coreactant ECL or cathodic coreactant
ECL.81 In fact, coreactants are the intermediate species when electrochemically oxidize
or reduce yield high redox power radical species for further chemical reactions in ECL
processes. This ECL route has been used to enhance ECL greatly even for strong ECL
emitters such as Ru(bpy)32+. Figure 1.4 shows three commonly used ECL coreactants.

Figure 1.4 Molecular structures of some common ECL coreactants.
Note: (a) Tri-n-propylamine (TPrA), (b) oxalate, and (c) persulphate salt.

The used coreactant should not itself generate any ECL, otherwise there would be
an interference with the analyte in solution. Additionally, the oxidation and reduction of
the coreactant and analyte should be simultaneous after which there occurs chemical
reaction followed by the electrochemical redox reaction at the surface of the electrode. As
demonstrated in Scheme 1.2, the coreactant approach was first introduced by Bard et al.,
where ECL was studied in acetonitrile in the absence and presence of several
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luminophores such as rubrene, DPA, Ru(bpy)32+, and Os(bpy)32+. TPrA and oxalate
belong to the class of anodic ECL coreactants, whereas BPO and persulfate belong to the
class of cathodic ECL coreactants. As shown in Scheme 1.2a., electrochemical oxidation
of oxalate and Ru(bpy)32+ occurs simultaneously in the anodic region (upon application
of positive potential), a strong reducing agent, CO2•– with a high reduction power is then
produced after oxidized. Thus, in situ formed radical anion undergoes e.g., chemical
reaction with the oxidized cation Ru(bpy)33+ to yield the excited state of Ru(bpy)32+( i.e.,
Ru(bpy)32+*) generating ECL.
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Scheme 1.2 Coreactant mechanisms route in typical ECL processes. (from
ref.71,83).
Note: ECL mechanistic pathways for Ru(bpy)32+ with both reductive ((a) Oxalate, (b) TPrA) and oxidative ((c) persulfate, (d) BPO)
coreactants.

Similarly, the oxidation of TPrA and Ru(bpy)32+occurs simultaneously in the
anodic region, a strong reducing agent TPrA• with a high reduction power is produced
after oxidized. This TPrA• free radical produced chemically after deprotonation
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encounters the oxidized cation Ru(bpy)33+ to yield the excited state Ru(bpy)32+ (i.e.,
Ru(bpy)32+*) producing ECL as illustrated in Scheme 1.2b.
The ECL mechanism with cathodic coreactants, such as BPO and persulfate, is
completely reverse to that of ECL mechanism of anodic coreactants described previously.
With cathodic coreactant, such as persulfate (S2O82-), the reduction of persulfate and
Ru(bpy)32+ occurs simultaneously at the cathode, a strong oxidant, SO4•- with a high
oxidizing power, is then produced after reduction. Thus, SO4•- anion free radical
produced encounters reduced cation Ru(bpy)3+ to form the excited state of Ru(bpy)32+
(i.e., Ru(bpy)32+*) producing ECL as seen in Scheme 1.2c. Similarly, when BPO is used
as cathodic ECL coreactant, the reduction of BPO and Ru(bpy)32+ occurs simultaneously
at the cathode, a strong oxidant, BPO•- with a high oxidizing power is then produced after
reduction of BPO. BPO•- quickly undergoes chemical decomposition to yield BPO• free
radical that chemically reacts with the reduced cation Ru(bpy)3+ to yield the excited state
of Ru(bpy)32+ (i.e., Ru(bpy)32+*) generating ECL as illustrated in Scheme 1.2d.
1.3 Unique Features of ECL69,71
ECL bridges the traditional fields of analytical electrochemistry with
luminescence spectroscopy, and offers several distinct advantages over other
spectroscopic-based detection system.
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(1) Compared with fluorescence (FL) methods, ECL does not need a light source,
which effectively frees the ECL from scattered-light and luminescent impurity
interferences.
(2) Although ECL is a form of chemiluminescence (CL), in which both ECL and
CL involve the light production by species that can undergo highly energetic electron
transfer reactions. CL is initiated by the mixing of needed reagents with carefully
controlling of their fluid flows. In contrast, ECL stars with electrochemical reactions by
controlling electrode potential, scan rate, and position.
(3) ECL can be more selective than CL because the type of excited states may be
controlled by varying the electrode potential.
(4) ECL generally is a nondestructive technique, in which the ECL emitter can be
re-generated after the ECL emission, thereby providing high sensitivity.
The above statements are supported by several recent studies,84-86 where different
immunoassays based on enzyme-linked immunosorbent assay (ELISA),
chemiluminescence (CL), ECL, and FL were compared, and ECL-based immunoassays
were found to have excellent reproducibility and sensitivity over other assays. Therefore,
ECL-based sensing systems will offer several unique features, which include high
sensitivity, good selectivity, low background, integrated versatility, excellent
reproducibility, and fast sample analysis.
1.4 Implications of ECL
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Sensitivity and selectivity are desirable attributes of any ECL based detection
system for detecting specific molecules of interest with many components. Sensitivity, in
DNA hybridization and other bioassays for the detection of biomolecules of interest, is
important in clinical diagnostics,87-90 forensic chemistry,90,91 environmental
investigations,92,93 pharmaceutical studies,94,95 and biological warfare agent detection.96103

Thus, ECL provides sensitive and selective detection of molecules of interest should

have broad applicability in all of these fields. A number of ECL reviews83,104-115 have
been available as ECL has been aggressively employed in clinical diagnostics because of
the sensitivity, selectivity, and stability of ECL based biosensors.
Since ECL itself is not the stand alone technique, ECL needs to be coupled with
various separation techniques, specifically liquid chromatographic techniques (high
performance liquid chromatography or HPLC116-123, flow injection,124-129 capillary
electrophoresis or CE130-135 ) for determination and analysis of analytes in matrix.
Biological threat agents have been detected with ECL and fluorogenicchemiluminescence (FCL) based assays. ECL detection was found to be more sensitive
for the detection of bacteria, viruses, and toxins whereas FCL has been considered as
more versatile for effective sample clean-up and high throughput screening of complex
samples.
Magnetic beads based ECL assays have been used with conjecture with a
technology called systematic evolution of ligands by exponential enrichment (SELEX).136
Instead of using protein-based antibodies in most common immunoassay formats, highly
specific receptors formed from oligonucleotides called aptamers have been utilized.
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Numerous label free aptamer based ECL detection has been investigated.137-154
Amplification of binding receptors can be procured via PCR (polymerase chain
reaction).Various immobilization ECL formats (immunoassays as well as DNA
hybridization) can be found in ECL literature utilizing classical ECL luminophores,155-161
semiconductor nanoparticles or quantum dots (QDs),162-165 metal nanoparticles
(NPs),105,166-171 carbon nanotubes (CNTs) 172-177 and graphene,139,178-186 for improving
performance of developed ECL biosensors. Very sensitive and precise DNA assays
labeled with Ru(bpy)32+ derivatives have been presented.187 Recent reports on DNA
assays witnessed the limit of detection (LOD) as 20 DNA copies per mL in plasma or
serum and 80 copies per mL in whole blood of varicella-zoster virus.188 On a separate
paper, a threshold of 10 DNA copies of Epstein–Barr virus has been mentioned.189
Quantification of DNA or messenger RNA by reverse transcription PCR based on
Ru(bpy)32+-ECL has been performed using commercial QPCR System 5000® from
Perkin–Elmer190 and the Origen® Analyser from Igen191 down to attomolar level
immobilized on a solid support (magnetic beads) using biotin-streptavidin chemistry.
Latest ECL applications include lab-on-a-chip approaches paper based ECL.192-195
1.5 Selected Examples of Application of ECL for Detection of Analytes
1.5.1 Analyte binding methods used in ECL based detection
There is an increasing need for rapid, highly specific methods of detecting and
quantifying small quantities of analytes such as chemical, biochemical, and biological
substances. The presence of these materials can often be determined by binding methods
that exploit the high degree of specificity which characterizes many biological systems.
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Known methods that rely on binding to detect a molecule of interest in a sample include
nucleic acid hybridization techniques and protein-ligand interactions such as antibodyantigen binding (Figure 1.5).72 In these methods, a positive value is typically indicated
either by the presence or the absence of an observable label (e.g., an ECL label) that has
been attached to one or more of the materials comprising a diagnostic complex. For
example, in the first case of DNA detection (Figure 1.5a), a target single-stranded DNA
(ssDNA) with an ECL label attached hybridizes with a ssDNA probe that immobilized on
a solid substrate.196,197 Under the same experimental conditions, ECL produced from the
complementary ssDNA hybridization will be higher than that obtained from noncomplementary one. The sandwich type format shown in Figure 1.5d196,198 is the most
commonly used means of ECL detection of an antigen (or a biomarker). Also, direct
interaction between the capture antibody and corresponding labeled antigen is possible
(Figure 1.5e), although in this case the pretreatment of the antigen (analyte) with the ECL
label, and subsequent separation of the free ECL labels from the antigen-ECL label
conjugates would be required, which could dramatically slow down the entire detection
progress as compared with the sandwich type assays, where both surface-confined and
ECL labeled antibodies can be pre-prepared. In a competition assay format (Figure 1.5f),
the unlabeled antigen blocks the ability of the labeled antigen to bind. As a result, less
label measured in the assay means more of the unlabeled (test sample) antigen is present.
In other words, the amount of antigen in the test sample is inversely related to the amount
of label measured in the competitive format.
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Figure 1.5 Examples of solid-phase ECL assay formats (from ref.72).
Note: (a) DNA hybridization assay based on an immobilized ssDNA hybridizes with a labeled target ssDNA., (b) sandwich type DNA
biosensor, (c) an assay used for integrase activity test with immobilized and free labeled dsDNA, (d) sandwich type immunoassay, (e)
direct immunoassay, (f) competitive assay in which analyte competes with labeled analyte for antibody binding sites on immobilized
antibody, (g) protease activity assay where cleavage of the immobilized peptide results in the decrease in ECL emission due to the
removal of the ECL label, (h) kinase activity assay using a labeled antibody to recognize the phosphorylated product.

1.5.2 Sensitive detection of specific ion
A new type of Hg2+ selective ECL biosensor with an extremely low detection
limit of 2.4 pM and high stability has been recently reported on the basis of mercuryspecific oligonucleotide (MSO). MSO served as a molecular recognition element and a
Ru(bpy)32+ derivative as an ECL emitting species. As shown in Figure 1.6, the MSO is
covalently attached to the surface of carboxylated single-wall carbon nanotubes (SWNTs)
on a glassy carbon electrode via an appropriate length of spacer. G4 PAMAM dendrimer
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with heavily loaded Ru(bpy)32+ derivatives are tethered to the other end of the MSO. In
the presence of Hg2+ ions, the initial linear MSO bends to form a “hairpin” type structure
after the complexation reaction between Hg2+ ions and thymine bases, which leads to the
ECL labels become closer to the electrode surface. Thus, a significant increase in ECL
intensity was observed with the Hg2+ bound ECL biosensor upon the anodic potential
scanning or pulsing in the presence of TPrA coreactant.

Figure 1.6 Working principle of the Hg2+-ECL detection (from ref.199).

1.5.3 “High amplification” strategy of ECL detection
In ECL analysis, ECL active labels that are attached to the target biomolecule
produce a measurable signal. The intensity of the measured signal is generally
proportional to the amount of the target species bound on the electrode. Traditionally,
only one or few labels can be attached directly to one target biomolecule, so that
nonspecific adsorption can be avoided and the bioactivity of the target biomolecule
remains. By utilizing polystyrene microspheres/beads (PSB) as the carrier of a large
19

number of hydrophobic ECL labels (i.e., Ru(bpy)32+) an ultrasensitive methodology for
DNA hybridization detection,156 sandwich-type immunoassay of C-reactive protein
(CRP),155 and the detection of high explosive 2,4,6-trinitrotoluene (TNT)-contaminated
soil and creek water samples161 has been demonstrated.
The principle of this type of strategy is shown in Figure 1.7. For DNA detection
(Figure 1.7a), a known sequence ssDNA (probe ssDNA) is first immobilized on the
surface of a magnetic bead (MB). The complementary ssDNA (target ssDNA)-coated
PSB bead that contains a large number of ECL labels (e.g., water insoluble Ru(bpy)32+,
~109 molecules/bead) hybridizes with the probe ssDNA to form a [(probe ssDNAMB)/(target ssDNA-PSB)] aggregate. Finally, this aggregate is magnetically separated
from the reaction mixture and transferred into an acetonitrile (MeCN) solution, in which
the PSBs dissolve and the ECL label is released. Light emission from the released ECL
labels is subsequently measured in MeCN in the presence of a coreactant, such as TPrA,
at a Pt electrode. A similar approach based on a sandwich-type of immunoassay can be
used for the detection of an antigen (e.g., CRP and TNT), as displayed in Figure 1.7b.
Clearly, there is no need for direct attachment of the ECL labels to ssDNA or antibodies
in the present technique, therefore a high loading capacity of the ECL labels per PSB,
hence a very large amplification factor of the ECL label molecules for each molecule of
analyte can be achieved, given that a limited number of capture ssDNA or antibody
species are attached to one PSB via the immobilization layer (of avidin).
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Figure 1.7 Schematic diagram of (a) DNA hybridization, and (b) sandwich type ECL
immunoassay (from ref.72).
Note: Polystyrene beads were used as the ECL label carrier and magnetic beads were used for the separation of analyte-containing
ECL label/polystyrene beads.

With the above PSB-based “high amplification” technique, a detection limit of 1.0
fM (1.0×10-15 M) for a t-ssDNA was achieved,197 along with a 100-fold improvement in
the sensitivity in the CRP determination198 compared to a previously reported surface
immobilized ECL method.196 Likewise, a limit of detection of 0.10 ppt TNT was
obtained,200 which is about 600 times lower than recently reported data using “a novel
surface plasmon resonance immunosensor.”201
Similar idea has been extended to ECL detection in aqueous media. Instead of 10
μm in diameter PSBs, ~100 nm in diameter sized liposomes as the ECL label carrier were
used in CRP detection.202 The release of the ECL label from liposomes was realized by
using 0.1 M TPrA and 0.1 M phosphate buffer (pH 7.6) containing 0.1 M NaCl and 1%
(v/v) Triton X-100.
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1.5.4 Lab on a chip and paper based ECL
Recent advancement in the field of ECL has made possible an exciting invention
of a kind of paper substrate micro-fluidic chip of bipolar electrode ECL and application
in imaging and sensing. This can be realized in practice by utilizing carbon paste as
bipolar electrode on paper for development of ECL chip for imaging, sensing, and
detection of TPrA. This invention exploits the proof of concept of paper substrate microfluidics.
Another recent report203 described the development of an ECL sensor fabricated
utilizing paper microfluidics with and without the use of conventional photodetectors.
Paper based microfluidic sensor was designed with inkjet printing were combined with
screen-printed electrodes (SPEs) to create simple, cheap, disposable using conventional
as well as mobile phone camera. Using conventional photodetector, a LOD of 2(dibutylamino)ethanol (DBAE) and nicotinamide adenine dinucleotide (NADH) was 0.9
μM and 72 μM, respectively, whereas 250 μM DBAE was detected using the phone.
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Figure 1.8 Fabrication and operation of a paper-based microfluidic ECL sensor. (from
ref.203).
Note: The individual paper fluidic elements were cut to size and the hydrophilic portion filled with a 10 mM Ru(bpy)32+ solution
before drying. The paper substrate was then aligned and fixed onto the face of the SPE by laminating with transparent plastic. Finally,
a drop of sample is introduced through a small aperture in the plastic at the base of the channel, and when the detection zone was fully
wetted, the sensor was placed close to the lens of the camera phone, a potential of 1.25 V was applied, and the resulting emission was
captured and analyzed.

A wide range of ultrasensitive detection of analytes using ECL can be found in
the literature.113,138,143,148,153,156,161,204-206
1.6 Ultraviolet-Visible Spectroscopy
Ultraviolet–visible spectroscopy (UV-Vis or UV/Vis) is an absorption
spectroscopic technique in which absorption of light intensity by a molecule in a sample
in UV-Vis region. UV-vis technique is based on Beer’s law, which can be expressed as
shown below in Equation 1.14 as:
A = ɛ.b.C

(1.14)
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where A is the absorbance, ɛ, the molar extinction coefficient (molar absorptivity) in the
units of L mol-1.cm-1, b, the path length of the cuvette (cm), and C is the concentration in
mol L-1. During an absorption process, an electron from the ground energy state promotes
to the higher energy level of excited state. Because we measure the absorbed light by the
sample of interest, the detector is aligned along with the light source and sample holder.
1.6.1 Application of UV-Vis in ECL
UV-Vis spectroscopy is employed to obtain an optimum fluorescence. For
optimum fluorescence, one needs a right excitation wavelength that can be obtained by
speculating at what absorption wavelength the molecule absorption is maximum in UVVis spectra. This wavelength is often the correct excitation wavelength in fluorescence.
UV-Vis spectroscopy could help us to understand the energy or electron transfer
mechanism and has found many applications in biomolecule detection.181,207-211
1.7 Fluorescenece Spectroscopy
Fluorescence spectroscopy is an emission spectroscopic technique utilized to
record florescence or emissive light from a sample when UV or visible light is externally
applied to excite the electrons in a molecule. The energy of light emitted is the energy
level difference between the lower and upper energy levels before and after the
promotion of electron(s) by irradiation of external light source. Absorption and emission
are the complementary processes. Because, light source is applied externally to excite the
electrons, the emissive light or florescence is measured by placing the detector 90 degrees
against the light source-sample array to measure the emitted light.
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1.7.1 Application of fluorescence in ECL
Theoretically, ECL emission spectrum could overlap with the fluorescence
emission spectrum from the same luminophore under study. However, this is not always
the case. For example, in the case of quantum dot luminophores that are not properly
capped, there could be some shift in the peak emission wavelengths. To verify whether
the ECL has been generated from the same luminophore or luminophore with some redox
impurities contaminated with, one can compare the ECL spectrum with the fluorescence
spectrum using identical solvent system. Absorption and emission are the crucial steps to
understand the energy transfer between acceptor and donor molecules in mixed ECL
emitter systems. One example of such energy transfer is the fluorescence resonance
energy transfer (FRET) between two luminophores that emit light at two different or
close emission wavelengths (Figure 1.8). One way of investigating this type of energy or
electron transfer between two luminophores is to see if there is any spectral overlap
between the emission of donor luminophore and the absorption of acceptor luminophore.
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Figure 1.9 Schematic of FRET process (from ref.176).
1.8 Electron Paramagnetic Resonance (EPR) Spectroscopy
Electron paramagnetic resonance (EPR) or electron spin resonance (ESR)
spectroscopy is a technique utilizing for studying materials with unpaired electrons. The
fundamental principles behind EPR spectroscopy are analogous to that of nuclear
magnetic resonance (NMR). EPR utilizes the excitement of electron spin whereas in
NMR, the spins of atomic nuclei are excited. EPR offers great specificity because
ordinary chemical solvents and matrices do not give rise to EPR spectra. For
understanding origin of an EPR signal,212-215 the electronic levels of an atom in a
molecule should be considered. Each electron has a magnetic moment and spin quantum
number, s = 1/2, with magnetic components ms = +1/2 and ms = -1/2. In the presence of
an external magnetic field with strength Bo, the electron’s magnetic moment aligns itself
either parallel (ms = -1/2) or antiparallel (ms = +1/2) to the magnetic field (Figure 1.10),
each alignment having a specific energy due to the Zeeman effect. The separation
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between the lower and the upper state for unpaired free electrons is accompanied by
either absorbing or emitting a photon of energy (ΔE) equal to hν such that the resonance
condition is obeyed as shown in Equation 1.15.
ΔE = hν

(1.15)

where h is the Planck's constant (h = 6.626× 10-34 J•s) and 𝜈 is the frequency of the
radiation. This leads to the fundamental equations of EPR spectroscopy:
hν = geμBBo

(1.16)

where ge equals to 2.0023 for the free electron and μB is the Bohr magneton.

Figure 1.10 Energy diagram showing splitting of the energy levels is directly proportional
to the strength of magnetic field.
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1.8.1 Application of EPR in ECL
ECL generation always involves anionic, cationic, and free radicals. As a result,
EPR could play an important role in monitoring the reaction process and in providing
critical information for proposing ECL mechanisms. Previously, EPR signals obtained
from TPrA•+ cation radical after its oxidation has been reported.216 Very recently,
hydroxyl radical OH•, which is an intermediate of cathodic ECL coreactant H2O2
reduction, as well as its stability in H2O-CH3CN mixtures, has also been published.217
1.9 Scope of This Dissertation
There has been ongoing rapid use of ECL in quantification and analysis of
clinical, food, and environmental samples; however, there are very few studies found in
the literature for ECL based multiplexed assays. Thus, there is a need for urgent and
immediate measures to be taken to detect and quantify multiple analytes per assay with
high throughput. One could save time, money, and effort by collecting multiple data at
one time with the use of multiple emitters (labels). For this, it is important to study the
systematic ECL titration behavior of mixed and unmixed systems of multiple efficient
ECL emitters before their potential applications in multiplexing detection of
biomolecules could be realized. This dissertation focuses on search for favorable ECL
coreactants by screening various commonly used ECL coreactants that suit in both
unmixed and mixed systems of emitter-coreactant combination. This dissertation also
provides insights into optimizing experimental conditions, which include effects of
electrode material, molecular oxygen (only applicable to cathodic coreactants),
concentration of ECL emitter, coreactant, and solvent on ECL signal intensities. The
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interaction studies of the multiple efficient ECL emitters with common favorable
coreactant in their mixed systems are also the focused area of this dissertation. The
synthesis of water soluble analogues of DPA and RUB, viz. 9,10-diphenylanthracene
sulfonate (DPAS) and sulfonated rubrene (SRUB), electrochemical and ECL studies of
the synthesized emitters, and methods to improve ECL signals of the emitters all comes
under the scope of this dissertation. EPR studies of ECL coreactant intermediates of
cathodic ECL coreactants, namely benzoyl peroxide and persulfate, that generate
benzoyloxy free radical (BPO•) and sulfate anion radical (SO4•̶̶̶̶) were conducted. Finally,
sensitive and selective ECL detection of zika and dengue viruses is achieved with the use
of effective and efficient emitter-coreactant combination.
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CHAPTER II - COREACTANT ECL STUDIES OF UNMIXED AND MIXED
SYSTEMS OF 9,10-DIPHENYLANTHRACENE, RUBRENE, AND TRIS(2,2'BIPYRIDINE)RUTHENIUM(II) IN ACETONITRILE
2.1 Introduction
A biosensor is an analytical device for detection and quantification of biological
species (e.g., bacteria, viruses, antigens, enzymes, nucleic acids) through a variety of
transducers that convert chemical information (e.g., identity and concentration of analyte)
into a measurable signal (e.g., current, voltage, mass change, and optical intensity).
Electrogenerated chemiluminescence (ECL) based biosensors use the ECL emission to
probe target biomolecules. The Ru(bpy)32+-TPrA system has been the most commonly
used coreactant ECL system in the literature for determination of various analytes,120

although the Ru(bpy)32+-DBAE (DBAE = 2-(dibutylamino)ethanol) system has

recently shown some promising results.21-29 To measure multiple analytes in a sample
simultaneously, a multiplexing detection method must be developed. When ECL is used
as a sensing element, multiple efficient ECL emitters present in the same sample matrix
could be required. Spectroscopically, however, how these ECL emitters interact each
other in the same solution under the ECL experimental conditions remains unclear.
ECL is a relatively new analytical technique, which has vast applications in the
areas of e.g., (a) life sciences for the discovery of new drugs and important biological
markers, (b) clinical utilities such as screening, monitoring, and diagnosing specific
biomolecules associated with certain types of diseases, and (c) industrial management
and bio-defense for monitoring and identification of bacteria, toxins, chemical warfare
agents, explosives, and other pathogens in food and environmental samples.218 It would
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be beneficial to college students majoring in e.g., chemistry, biochemistry, forensic
chemistry, and environmental sciences to be exposed to ECL technology. However, the
current textbooks of analytical and instrumental analysis lack the relevant contents. In
fact, ECL theory and ECL labs could fit perfectly with any modern analytical chemistry
especially instrumental analysis textbooks. This is because, scientifically, ECL is a
perfect connection among the three-traditional instrumental analysis course components
— spectroscopy, electrochemistry, and separation methods. ECL is a process of light
generation (spectroscopy) via redox reactions (electrochemistry), and has been used as a
transducer (detector) in flow injection, liquid chromatography, and capillary
electrophoresis (separation methods) and micro total analysis.
In this chapter, ECL behavior of unmixed and mixed systems of three efficient
ECL emitters, namely 9,10-diphenyanthracene (DPA), rubrene (RUB), and Ru(bpy)32+, is
studied with several common ECL coreatants, using an inexpensive homemade
electrochemical-ECL-spectroscopic instrument. The data obtained will provide some
fundamental information for future use in multiplexing ECL detection, and the
constructed instrument can be used for college level ECL labs in instrumental analysis.
Such electrochemistry-ECL-spectroscopy integrated labs will offer several advantages
including (a) more efficient utilization of laboratory equipment, and (b) challenging
students with critical thinking of different categories of instrumental techniques.
Previously, there have been some efforts on constructing and conducting ECL labs for
college students.219,220 The instrumentation and experiments presented in this chapter,
however, are new.

31

2.2 Experimental Section
2.2.1 Chemicals
Unless otherwise stated, all chemicals were of analytical grades and used as
received. Tris(2,2′-bipyridyl)ruthenium perchlorate [Ru(bpy)3(ClO4)2], tri-n- propylamine
(TPrA, 99+%), rubrene (RUB, 98%), hydrochloric acid (HCl, 37.5%), benzoyl peroxide
(BPO, 97%), and 2-(dibutylamino)ethanol (DBAE, 99%) were purchased from Sigma
Aldrich (St. Louis, MO). Methanol (spectroanalyzed grade), 9,10-diphenylanthracene
(DPA, 98%), and tetra-n-butylammonium perchlorate (TBAP, 99+%, electrochemical
grade) were obtained from Fluka (Milwaukee, WI). Acetonitrile (MeCN, 99.93+%,
HPLC grade) was purchased from MP Biomedicals (Solon, OH).
2.2.2 Spectral ECL Instrument Setup
The schematic diagram of spectral ECL instrument setup is shown in Figure 2.1,
where a portable “WaveNow” potentiostat (Pine Research Instrumentation) is coupled
with a Hamamatsu TG-series mini-spectrometer (Hamamatsu Photonics Inc.).221 A laptop
computer installed with “AfterMath” software from Pine Instrumentation and
“SpecEvaluation” software from Hamamatsu was used to control both the potentiostat
and mini-spectrometer as well as to display both the electrochemical responses and ECL
spectra. The connection between the computer and potentiostat or mini-spectrometer was
done with a USB cable. ECL emissions generated at the working electrode were collected
and sent to the mini-spectrometer via an optical fiber before displayed on the computer
screen. Note that when electrochemical and ECL experiments were conducted, both
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“AfterMath” and “SpecEvaluation” software must be open and run simultaneously. For
the electrochemical cell system, either a screen-printed electrode (SPE, e.g., ceramic Au
or Pt SPEs) or a traditional three-electrode system can be used.
The above constructed spectral ECL instrument is relatively inexpensive, easy to
operate, very portable, and well adaptable to various levels of teaching and learning
environments.

Figure 2.1 Schematic diagram of spectral ECL instrument setup.
Note: (A) computer, (B) potentiostat/galvanostat, (C) electrochemical cell with a three-electrode system, and (D) mini-spectrometer.

2.2.3 Electrochemical and ECL measurements
A traditional three-electrode electrochemical cell system was used, with either a
Pt (2.0 mm), Au (2.0 mm), or glassy carbon electrode (GCE, 3.0 mm) as the working
electrode, a Ag/Ag+ (10 mM AgNO3 in 0.10 M TBAP in MeCN) as the reference
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electrode, and a Pt mesh as the counter electrode, respectively. All these electrodes were
purchased from CH Instruments (Austin, TX). A disposable 5 mL glass vial was used as
the cell. The working electrode was polished with 0.3 µm alumina and washed with
deionized (DI) water (Elix Advantage Water Purification System, EMD Millipore,
Darmstadt, Germany), and sonicated in nitric acid and toluene, respectively. This was
followed by rinsing the electrode with ethanol, DI water, and acetonitrile, respectively,
and then drying with Kimwipes tissue. The vycor tip of the Ag/Ag+ reference electrode
was replaced whenever needed to prevent from susceptible cross contamination. All
solutions involving cathodic reduction reactions were pre-degassed with ultrapure
nitrogen gas (Airgas, Hattiesburg, MS), and all experiments were conducted at room
temperature 20 ± 1 °C.
2.3 Results and Discussion
2.3.1 Selection of ECL emitters and their CV studies
There are a huge number of ECL emitters reported in the literature. For this study,
however, 9,10-diphenylanthracene (DPA), rubrene (RUB), and Ru(bpy)3(ClO4)2 (Figure
2.2) were chosen, because (a) they are readily available commercially, (b) they have
shown well defined reversible redox behavior in acetonitrile (MeCN) that is the most
commonly used organic solvent for electrochemical and ECL studies, (c) the ion
annihilation ECL data indicated that their ECL efficiencies are among the highest in the
ECL emitters ever studied, and (d) their ECL emission spectra are well separated from
one to another, which is desirable for spectral separation based multiplexing ECL
detection. Table 2.1 lists the redox potential, ECL efficiency, and ECL emission values of
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DPA, RUB, and Ru(bpy)32+ species. Note that 25% efficiency for DPA represents the
theoretical maximum for ECL from DPA singlets.222 Although the counter ion of
Ru(bpy)32+ will not affect the ECL behavior, to avoid possible influence of water,
Ru(bpy)3(ClO4)2 rather than hydrated Ru(bpy)3Cl2• 6H2O was used.

Figure 2.2 Molecular structures of ECL emitters under study (a) DPA, (b) RUB, and (c)
Ru(bpy)32+.
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Table 2.1 Redox potential, ECL efficiency, and ECL emission values of DPA, RUB, and
Ru(bpy)32+ species.

Redox Potential (V, vs SCE)
Ion
Annihilation
ECL
efficiency

ECL
Labels

E1/2(ox)

E1/2(red)
Media

Ref.
223

This
work

Ref.
223

ECL Emission
(max, nm)

ECL

This
work

Ref. 224

This
work

DPA

+1.29

+1.03

-1.96

-2.24

MeCN

25%222

~420

~420

RUB

+0.82

+0.84

-1.56

-1.79

1:1
MeCN
/PhH

25%225

~540

~545

Ru(bpy)32+

+1.35

+1.05

-1.32

-1.63

MeCN

5%226

~620

~630

Figure 2.3 shows the cyclic voltammograms of DPA, RUB, and Ru(bpy)32+,
respectively, in which a mixed solvent system of MeCN/PhH (1:1, v/v) is used for RUB
study due to its poor solubility in pure MeCN solvent (< 100 μM). Although benzene and
phenolic moieties help increase solubility of RUB but could quench ECL significantly.227229

All three ECL emitters undergo reversible one-electron transfer oxidation and

reduction reactions. It is believed that Ru(bpy)32+ oxidation occurs at the metal center,
i.e., [RuII(bpy)32+]  [RuIII(bpy)32+], whereas the reversible three one-electron transfer
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processes are contributed to the reduction of the bpy ligand.230 Table 2.1 lists the halfwave potential of the first oxidation and reduction process of the three emitters, where a
potential value of 0.186 V vs standard hydrogen electrode (SHE) for Ag/Ag+ (10 mM) in
MeCN and 0.241 V vs SHE for saturated calomel reference electrode (SCE, Hg/Hg2Cl2
(sat., KCl)) was used, respectively, for the conversion of the redox potential.2 Close
inspection of Table 2.1 reveals that the redox potential difference between the oxidation
(E1/2(ox)) and reduction (E1/2(red)) is nearly identical when comparing the literature value
with the one of this work for both DPA (3.25 vs 3.27 V) and Ru(bpy)32+ (2.67 vs 2.68
V),. This suggests that the difference in E1/2 value for the same redox process between the
literature value and the present one is due to the use of two different reference electrodes.
For RUB, however, a ΔE1/2 value of 2.38 V and 2.63 V is obtained from the literature and
present work, respectively. Considering the ECL emission of RUB at ~540 nm and
Ru(bpy)32+ emits at ~620 nm, one would expect a larger energy gap (or ΔE1/2 value)
between the excited and ground state for RUB as compared with that for Ru(bpy)32+.
Thus, for RUB the E1/2 values obtained from the present work are more reasonable.
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Figure 2.3 CVs of individual ECL emitters.
Note: CVs of (A)1.0 mM DPA in 0.10 M TBAP in MeCN, (B) 1.0 mM RUB in MeCN/PhH (1:1, v/v), and (C) 1.0 mM
Ru(bpy)3(ClO4)2 at a 2-mm Pt electrode with a scan rate of 100 mV/s.

2.3.2 Selection of ECL coreactants and working electrodes
ECL coreactants are important species that are deliberately added into ECL
emitter systems for obtaining efficient ECL emissions and ruling out the setbacks of
working with solvents that cannot withstand a large potential window. They can also
often overcome the problems associated with the instability of electrochemically
generated emitter cations or anions or the ECL quenching by oxygen in the air.
Tri-n-propylamine (TPrA) and 2-(dibutylamino)ethanol (DBAE) are commonly
used for anodic ECL, and benzoyl peroxide (BPO) and persulfate are for cathodic ECL.
Figure 2.4 shows the molecular structures of TPrA, DBAE, and BPO. As persulfate salt,
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such as ammonium persulfate or potassium persulfate is not soluble in acetonitrile, only
the three coreactants shown in Figure 2.4 were used for further studies.

Figure 2.4 Molecular structures of ECL coreactants under study (a) TPrA, (b) DBAE, and
(c) BPO.
The cyclic voltammograms of individual coreactants under study are shown in
Figure 2.5. At a Pt electrode, TPrA oxidizes at an onset potential of 0.20 V Ag/Ag+ and a
peak potential of 0.49 V vs Ag/Ag+ (Figure 2.5a). Similarly, an onset potential of 0.34 V
vs Ag/Ag+ and a peak potential of 0.94 V vs Ag/Ag+ for DBAE oxidation are observed
(Figure 2.5b). On the other hand, BPO reduction occurs at 0.50 V vs Ag/Ag+ with a peak
reduction potential of -1.60 V vs Ag/Ag+ (Figure 2.5c). The irreversible CV behavior of
all three coreactants is consistent with the fact that the newly generated chemical species
at the electrode underdoes immediately a series of chemical reactions in the solution so
that no electroactive species remain when the electrode potential is scanned on the
reverse direction.112
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+
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Figure 2.5 CVs of individual ECL coreactants.
Note: CVs of (a) 25.0 mM TPrA, (b) 25.0 mM DBAE, and (c) 10.0 mM BPO in MeCN containing 0.10 M TBAP at a 2-mm Pt
electrode with a scan rate of 100 mV/s.

Electrode material can affect the redox behavior of coreactant, which is directly
correlated to the ECL generation of a coreactant ECL system. Generally, the more
coreactant reacts at the electrode, the more intermediates needed for ECL production are
formed, thus the stronger the ECL intensity will be. Figure 2.6 shows the CVs of BPO at
Pt, Au, and GCE. It is clear that in MeCN, Pt is the most favorable working electrode for
BPO reduction, followed by Au electrode and then GCE. Previously, Pt has been shown
to play a catalytic role towards many electrochemical processes.231-237
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Figure 2.6 CVs of 10.0 mM BPO at different electrodes.
Note: All CVs were carried out in MeCN containing 10.0 mM BPO-0.10 M TBAP at a 2-mm Pt electrode with a scan rate of 100
mV/s. The solution was degassed for about 7 minutes with N2.

Initial ECL tests were conducted in a mixture solution of DPA, RUB, and
Ru(bpy)32+ using different ECL coreactants with linear sweep voltammetry. As shown in
Figure 2.7, not detectable, weak, and strong ECL spectra are observed when ECL
coreactant of TPrA (Figure 2.7a), DBAE (Figure 2.7b), and BPO (Figure 2.7c) are used,
respectively. Clearly, neither TPrA nor DBAE is a suitable common coreactant for the
mixture ECL system. This observation can be explained by the ECL mechanism.72 To
generate ECL from an ECL emitter DPA (or RUB), electrochemically oxidized DPA•+
(or RUB•+) cation must annihilate with its DPA•– (or RUB•–) anion to form an excited
state DPA* (or RUB*) that emits light. Because the redox potential of TPrA• free radical,
i.e., -1.7 V vs SCE,223 is less negative than that of -2.24 V for the DPA/DPA•– couple or 42

1.79 V vs SCE for the RUB/RUB•– couple (Table 2.1), no significant amount of DPA•–
(or RUB•–) anion is expected to produce. As a result, no or very weak ECL can be
generated. The redox potential of DBAE• free radical is not available in the literature; it is
estimated to be around -2.2 V vs SCE, because weak ECL responses are seen in the ECL
emission regions of the DPA/DBAE (~420 nm) and RUB/DBAE (~550 nm) systems
(Figure 2.7b). Note that TPrA• and DBAE• free radicals are produced after the
electrochemical oxidation of TPrA and DBAE and subsequent deprotonation reaction,
respectively.72 The above discussion, however, cannot be extended to the Ru(bpy)32+
case, as this system follows different ECL mechanisms.72
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Figure 2.7 ECL spectra obtained from a mixture of DPA, RUB, and Ru(bpy)32+.
Note: ECL spectra were obtained from a mixture of DPA (250.0 µM), RUB (25.0 µM), and Ru(bpy) 32+ (25.0 μM) in MeCN
containing 0.10 M TBAP with (a) 25.0 mM TPrA, (b) 25.0 mM DBAE, and (c) 10 mM BPO upon a linear potential sweep from 0 and
2.0 V for (a) and (b) or 0 and -3.0 V vs Ag/Ag+ for (c) at a 2-mm diameter Pt electrode at a scan rate of 100 mV/s. The solution was
degassed for about 7 min with N2 before ECL spectra were recorded.

In contrast, when the cathodic ECL coreactant BPO is used, remarkably strong
ECL emissions are observed for all the three ECL emitters (Figure 2.7c). Notably,
emission spectra from RUB (~550 nm) and Ru(bpy)32+ (~620 nm) are overlapped, which
can be deconvoluted as will be demonstrated later. Scheme 2.1 summarizes the ECL
mechanism of the R/BPO system (R = DPA, RUB, or Ru(bpy)32+) involving both the
energy-sufficient S-route and the energy-deficient T-route (Section 1.2.1 in Chapter I).72
Briefly, upon the cathodic potential scanning, both BPO and ECL emitter R are
electrochemically reduced to form BPO•– and R•– (Equations 2-1 and 2-2), and the former
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further decomposes to produce a strong oxidizing intermediate, namely benzoate radical
C6H5CO2• (Equation 2.4), with a redox potential value of > +1.5 V vs SCE.238 This is
followed by redox reactions between C6H5CO2• and R (Equation 2.5) as well as R•–
(Equation 2.6) to produce species (e.g., R•+, 1R*, and 3R*) necessary for ECL generation.
BPO + e → BPO•−

(2.1)

R + e → R•−

(2.2)

R•− + BPO → R + BPO•−

(2.3)

BPO•− → C6 H5 CO2 − + C6 H5 CO2 •

(2.4)

R + C6 H5 CO2 • → R•+ + C6 H5 CO2 −

(2.5)

R•− + C6 H5 CO2 • →

1 ∗

R + C6 H5 CO2 −

(2.6)

R•− + C6 H5 CO2 • →

3 ∗

R + C6 H5 CO2 −

(2.7)

R + R

(2.8)

3 ∗

R +

3 ∗

R →

1 ∗

3 ∗

R + BPO → R•+ + BPO•−

(2.9)

R + C6 H5 CO2 • → R•+ + C6 H5 CO2 −

(2.10)

3 ∗

R•− + R•+ →

1 ∗

R + R

(2.11)

1 ∗

R → R + hv

(2.12)

(R = aromatic hydrocarbons such as DPA or RUB and Ru(bpy)32+).
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Scheme 2.1 ECL mechanism with BPO as cathodic ECL coreactant.

Effect of electrode material on ECL production of the R/BPO system was
examined with the spectral ECL instrument. As shown in Figure 2.8, under the same
experiemntal conditions, among the three tested working electrodes (Pt, Au, and GCE),
Pt electrode produces the strongest ECL spectra for all three ECL emitters (Figure 2.8a),
whereas GCE only gives weak ECL responses (Figure 2.8c). The ECL intensity obtained
from Pt, Au, and GCE has an approximate ratio of 2.8/1.8/1 for Ru(bpy)32+, 3.8/1.9/1 for
RUB, and 3.7/2.2/1 for DPA, respectively. These findings are consistent with the CV data
shown in Figure 2.6, suggesting that the electrochemical reduction of BPO is a
determining step for the ECL generation of the R/BPO system. In addition, at Pt
electrode, the Ru(bpy)32+/BPO system produces nearly the same intense ECL as the
RUB/BPO system does, which is about 20% stronger than that from the DPA/BPO
system (Figure 2.8a).
Based on the above discussion, it is concluded that the combination of BPO
coreactant with Pt working electrode is the most favorable choice for ECL detection of a
mixture of DPA, RUB, and Ru(bpy)32+ emitters.
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Figure 2.8 Effect of electrode material on ECL intensity.
Note: Plot of changes in ECL intensity per unit area vs a fixed concentration of ECL emitters (i.e., 25.0 µM) using 10.0 mM
coreactant BPO (optimized concentration) in 0.10 M TBAP MeCN with a linear potential sweep from 0 to -3.0 V vs Ag/Ag+ at a scan
rate of 100 mV/s. Hamamatsu mini-spectrometer was used to collect ECL spectra.

2.3.3 Validation of the spectral ECL instrument
The performance of the newly constructed mini-spectrometer based spectral ECL
instrument was compared and validated with a homemade ECL setup that used a
photomultiplier tube (PMT) as a light detector.239 Due to its extremely high sensitivity,
the PMT based ECL instrument can detect ultra-low ECL emissions. Consequently, the
ECL responses of all the three coreactants (i.e., TPrA, DBAE, and BPO) coupled with the
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three ECL emitters (i.e., DPA, RUB, and Ru(bpy)32+) were recorded. Figure 2.9 shows
such results, where BPO yields the most efficient ECL intensities for all the three ECL
emitters, with a slightly less ECL intensity over the entire coreactant concentration range
from the DPA/BPO system as compared with the RUB/BPO or Ru(bpy)32+/BPO system.
Also, maximum ECL intensities appear at 10.0 mM BPO, which likely is explained by
the two opposing roles of BPO has during the ECL generation (Scheme 2.1). On the one
hand, BPO is needed for the production of BPO•−, C6H5CO2•, R•+, 1R*, and 3R*, which is
favorable to ECL generation. On the other hand, hoverer, BPO can react with the
electrogenerated R•− (Equation 2.3), which reduces the chance of the ion annihilation
reaction of R•+ + R•− → R* (Equation 2.11) and diminishes ECL generation. Significantly
weak ECL responses are seen from the systems using TPrA or DBAE as an ECL
coreactant, especially when DPA or RUB is used as an ECL emitter. As discussed earlier,
the insufficient reducing capacity of TPrA• and DBAE• free radicals towards chemical
reductions of DPA and RUB is probably the cause of such weak ECL emissions.
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Figure 2.9 ECL responses of various coreactant ECL systems measured with a PMT
based ECL instrument.
Note: Integrated ECL-intensities of three different ECL emitters (i.e., RUB, Ru(bpy)32+, and DPA, 25.0 μM each) were plotted against
various concentrations of three different co-reactants (i.e., BPO, DBAE, and TPrA). CV potential scanning between 0 and 2.0 V for
TPrA and DBAE or 0 and -3.0 V vs Ag/Ag+ for BPO in 0.10 M TBAP MeCN at a 2-mm Pt electrode with a scan rate of 100 mV/s
was used. The solution was degassed for about 7 min with N2 before ECL measurement was taken place.

It is evident that the data shown in Figure 2.9 are consistent with the data shown
in Figures 2.7 and 2.8, verifying that the constructed mini-spectrometer based spectral
ECL instrument performed well.
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2.3.4 Study of unmixed systems of ECL emitters
Figure 2.10 shows the ECL spectra of individual ECL emitter DPA (Figure
2.10A), RUB (Figure 2.10B), and Ru(bpy)32+ (Figure 2.10C) at various concentrations
when 10.0 mM BPO is used as the cathodic ECL coreactant, with a maximum ECL
emission at ~420 nm, ~545 nm, and 630 nm, respectively. These ECL peak values are in
good agreement with those reported previously from ion annihilation reactions (Table
2.1) as well as with fluorescence spectra displayed as an inset of the respective ECL
spectra (Figures 2.10A-C). An excellent linear relationship between the ECL emitter
concentration and the ECL peak intensity is shown in Figure 2.10D. Such a calibration
curve is useful for quantifying target analyte when the R/BPO system is used for ECL
based single or multiplexed assays.
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Figure 2.10 ECL spectra of (A) DPA, (B) RUB, and (C) Ru(bpy)32+ at various
concentrations using BPO as coreactant. (D) Relationship between the emitter
concentration and ECL peak intensity.
Note: All ECL measurements were carried out with the spectral ECL instrument in 0.10 M TBAP MeCN solution containing 10.0 mM
BPO and various concentrations of ECL emitter after degassed with N2 for 7 min at a 2-mm diameter Pt electrode over a linear
potential sweep from 0 to -3.0 V vs Ag/Ag+ at 100 mV/s. Insets in (A)-(C) were comparisons between ECL and fluorescence spectra.
For fluorescence experiments carried out with a PTI Qunata Master 40TM intensity based spectrofluoromter, 2.50 µM of each ECL
emitter in MeCN was used. The excitation wavelength for DPA, RUB, and Ru(bpy) 32+ was 370 nm, 490 nm, and 450 nm, respectively.
These wavelengths were the maximum absorption peak wavelengths of the emitters measured with a Beckman Coulter DU 800
UV/Vis spectrophotometers.

2.3.5 Study of binary mixed systems of ECL emitters
Among DPA, RUB, and Ru(bpy)32+ ECL emitters, three binary combinations of
them, namely, DPA-RUB, DPA-Ru(bpy)32+, and RUB- Ru(bpy)32+, were studies. Figure
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2.11 shows the ECL spectra of the (DPA-RUB)/BPO system with a constant
concentration of RUB (25.0 M) mixed with different concentrations of DPA. With the
increase of DPA concentration, ECL intensity at ~420 nm for DPA emissions increases
as expected. Meanwhile, the ECL intensity at ~540 nm for RUB emissions also increases
slightly. The inset in Figure 2.11 displays the linear responses of ECL intensities with the
concentration of DPA. The increase in RUB ECL with the increase of [DPA] can be
contributed to the energy transfer between DPA* and RUB as DPA* + RUB  RUB*.
This explanation is supported by the fluorescence spectra of DPA and the absorption
spectra of RUB (Figure 2.12), where partially overlap of the two spectra is evident.
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Figure 2.11 ECL spectra of the (DPA-RUB)/BPO system with a constant concentration
of RUB mixed with various concentrations of DPA.
Note: [DPA] was increased from 50.0 µM to 250 µM while [RUB] at 25.0 µM was held constant with 10.0 mM BPO as ECL
coreactant. All ECL measurements were carried out using the spectral ECL instrument in MeCN solution containing 0.10 M TBAP
supporting electrolyte after degassed with N2 for 7 min at a 2-mm diameter Pt electrode with at a CV scan rate of 100 mV/s.
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Figure 2.12 Fluorescence spectra of DPA and absorption spectrum of RUB.
Note: The experiments were carried out in MeCN. The slit width was 0.75 mm. The excitation wavelength for florescence experiment
was 370 nm.

The ECL behavior of the (DPA-Ru(bpy)32+/BPO system is shown in Figure 2.13.
Under a constant [DPA], the ECL intensity for Ru(bpy)32+ emissions at ~630 nm
increases with the increase of [Ru(bpy)32+], whereas the ECL signal for DPA emissions at
~420 nm decreases (Figure 2.13A). On the other hand, under a constant [Ru(bpy)32+], the
ECL intensity of DPA as well as Ru(bpy)32+ increases with the increase of [DPA] (Figure
2.13B), although in the latter case, the ECL intensity change is insignificant. These data
can be explained with the energy transfer between DPA* and Ru(bpy)32+ through a
reaction process of DPA* + Ru(bpy)32+  Ru(bpy)32+*, as illustrated by the partial
overlapping of the fluorescence spectra of DPA and the absorption spectra of Ru(bpy)32+
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(Figure 2.14). Fluorescence titration experiments of DPA with Ru(bpy)32+ (Figure 2.15)
further support the above explanation.
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Figure 2.13 ECL spectra of the (DPA-Ru(bpy)32+)/BPO system with a constant
concentration of (A) DPA and (B) Ru(bpy)32+ mixed with various concentrations of (A)
Ru(bpy)32+ and (B) DPA.
Note: (A) [Ru(bpy)32+] was increased from 25.0 µM to 125.0 µM while [DPA] at 200.0 µM was held constant, and (B) [DPA] was
increased from 200.0 µM to 400.0 µM while [Ru(bpy)32+] at 10.0 µM was held constant with 10.0 mM BPO as ECL coreactant. All
ECL measurements were carried out using the spectral ECL instrument in MeCN solution containing 0.10 M TBAP supporting
electrolyte after degassed with N2 for 7 min at a 2-mm diameter Pt electrode with at a CV scan rate of 100 mV/s.
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Figure 2.14 Fluorescence spectra of DPA and absorption spectra of Ru(bpy)32+.
Note: The experiments were carried out in MeCN. The excitation wavelength for DPA emission was 370 nm.
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Figure 2.15 Fluorescence spectra of DPA with the addition of various amounts of
Ru(bpy)32+.
Note: [DPA] was fixed at 2.5 µM whereas [Ru(bpy)32+] was gradually allowed to increase from 2.5 µM till 20 µM. The fluorescence
titration experiments were carried out in MeCN. The excitation wavelength was 370 nm and the slit width was 0.75 mm.

Finally, the ECL properties of the (RUB-Ru(bpy)32+)/BPO system were
investigated. Because the peak values of these two ECL emitters are relatively close (540
vs 630 nm) and their individual spectra are broad, experimentally obtained overall ECL
spectra as shown in Figure 2.16 are significantly overlapped. To resolve the peak
overlapping, “multiple peak fit” function within OriginLab software was used.
Specifically, two “biguanssian” peak functions with one peak located at ~540 nm for
RUB and the other at ~630 nm for Ru(bpy)32+ were initialized. The calculated best
overall fitting curve (solid line) was found to match well with the experimental data
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(Figure 2.16), where individual ECL spectra for each emitter (dashed lines) were also
displayed. As a result, the respective ECL intensity of RUB and Ru(bpy)32+ in the binary
system can be estimated. Note that such a spectral simulation or fitting is constrained by
the known ECL emissions including λmax values. Therefore, errors introduced by
deconvolution of experimentally obtained spectra are small. Spectral fitting of severely
overlapped peaks in high resolution X-ray photoelectron spectroscopy has been widely
used for many years.240 Figure 2.16A shows that the ECL intensity of RUB increases
with the increase of its concentration and the ECL for Ru(bpy)32+ remains unchanged
when a constant [Ru(bpy)32+] is used. The opposite is also true. As shown in Figure
2.16B, when [RUB] remains constant, the ECL intensity of Ru(bpy)32+ increases with the
increase of [Ru(bpy)32+], and the ECL of RUB is not influenced by the addition of RUB.
These data suggest that, unlike in the cases involving DPA (Figures 2.11 and 12), no
energy transfer between RUB and Ru(bpy)32+ exists. This is not surprising because the
energy difference between the two excited ECL emitters is rather close.
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Figure 2.16 ECL spectra of the (RUB-Ru(bpy)32+)/BPO system with a constant
concentration of (A) Ru(bpy)32+ and (B) RUB mixed with various concentrations of (A)
RUB and (B) Ru(bpy)32+.
Note: (A) [RUB] was increased from 25.0 µM to 125.0 µM while [Ru(bpy)32+] at 25.0 µM was held constant, and (B) [Ru(bpy)32+]
was increased from 25.0 µM to 125.0 µM while [RUB] at 25.0 µM was held constant with 10.0 mM BPO as ECL coreactant. All ECL
measurements were carried out using the spectral ECL instrument in MeCN solution containing 0.10 M TBAP supporting electrolyte
after degassed with N2 for 7 min at a 2-mm diameter Pt electrode with at a CV scan rate of 100 mV/s.

2.3.6 Study of ternary mixed systems of ECL emitters
In this section, ECL behavior of ternary mixed systems of (DPA-RUBRu(bpy)32+/BPO is presented. Figure 2.17 shows a typical ECL spectra obtained from a
mixture of DPA, RUB, and Ru(bpy)32+ using BPO as the cathodic coreactant. The peak at
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~420 nm for DPA emission is well separated from the overlapped broad peak at ~600 nm
for emissions from RUB and Ru(bpy)32+. Using the same strategy for the deconvolution
of mixed ECL spectra of RUB and Ru(bpy)32+ (Figure 2.16 in Section 2.3.5), this ternary
ECL spectra can be also well resolved with the “multiple peak fit” function in OriginLab
as demonstrated in Figure 2.17. Consequently, ECL intensities of respective individual
emitters can be estimated.
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Figure 2.17 Deconvolution of ECL spectra obtained from a mixture of DPA, RUB, and
Ru(bpy)32+.
Note: ECL spectra were obtained from a mixture of DPA (250.0 µM), RUB (25.0 µM), and Ru(bpy)32+ (25.0 μM) in MeCN
containing 10.0 mM BPO-0.10 M TBAP at a 2-mm diameter Pt electrode with a scan rate of 100 mV/s. The solution was degassed for
~7 minutes with pure nitrogen gas.
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Figure 2.18 shows three examples of the ECL responses from ternary mixed
systems of ECL emitters. In each case, concentrations of two of the three ECL emitters
remain unchanged, and the ECL intensity of each emitter is examined along with the
concentration change of the third emitter. Specifically, the effect of [DPA], [RUB], and
[Ru(bpy)32+] on the overall ECL behavior is revealed in Figures 2.18A, B, and C,
respectively. Detailed linear relationship between the individual ECL intensity and the
third ECL emitter concentration is plotted and placed aside of the ECL spectra as an
inset. These data can be explained using the energy transfer between the high energy
excited DPA* species and the ground state RUB or Ru(bpy)32+ to form a relatively low
energy excited state species of RUB* or Ru(bpy)32+*.
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Figure 2.18 ECL spectra of the (DPA-RUB- Ru(bpy)32+)/BPO system with the
concentration change of (A) DPA, (B) RUB, and (C) Ru(bpy)32+ while two other ECL
emitter concentrations remained unchanged.
Note: Experiments were carried out in MeCN solution containing 10.0 mM BPO-0.10 M TBAP after degassed with N2 for ~7 min at a
2-mm diameter Pt electrode with a CV scan rate of 100 mV/s.

Although energy transfer related interactions between ECL emitters were
observed, which seems to make the proposed three ECL emitters a bit unfit for potential
use in ECL based multiplexed assays, it is expected that this kind of interaction should
become negligible at a lower concentration range (e.g., sub-micromolar or below) that is
often the case in real sample analysis.
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2.4 Hazards
Polycyclic aromatic hydrocarbons (PAHs) have carcinogenic effects. Acute
(short-term) inhalation of acetonitrile exposure results in irritation of mucous membranes
whereas its chronic (long-term) exposure results in central nervous system effects, such
as headaches, numbness, and tremors. TPrA and DBAE are skin and eye irritants and the
solutions of these must be prepared under hood. BPO can be explosive if exposed to heat,
shock or friction.
2.5 Conclusion
An inexpensive and portable spectral ECL instrument was constructed. This setup
consisted of a portable “WaveNow” potentiostat from Pine Research Instrumentation and
a Hamamatsu mini-spectrometer, and was capable of conducting regular electrochemical
experiments and measuring ECL spectra. The newly homemade instrument was used to
study the cyclic voltammetry of individual ECL emitters (i.e., DPA, RUB, and
Ru(bpy)32+) and coreactants (i.e., TPrA, DBAE, and BPO) as well as the ECL behavior of
various combinations of ECL emitter-coreactant at different working electrodes (i.e., Pt,
Au, and GCE). The results from ECL titration studies of unmixed and mixed systems of
ECL emitters using the most efficient cathodic BPO coreactant at Pt electrode provided
fundamental data for ECL spectral based multiplexing detection of analytes. Certain
interactions between co-existing ECL emitters were explained with the energy transfer
from a high energy excited stated emitter to another relatively low energy ground state
emitter, which was supported by the fluorescence and absorption spectroscopic data.
Finally, the experimentally obtained overlapping ECL spectra were well resolved with
67

the “multiple peak fit” function of OriginLab program. Parts of the experiments reported
in this chapter were carried out with the integrated homemade spectral ECL instrument
can be well-adapted to various levels of analytical chemistry or instrumental analysis
teaching laboratories.
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CHAPTER III - SYNTHESIS, ELECTROCHEMISTRY AND ECL STUDIES OF
WATER SOLUBLE ANALOGUES OF 9,10-DIPHENYLANTHRACENE AND
RUBRENE WITH NITRATE AS ECL ENHANCING AGENT
3.1 Introduction
The sensitive ECL detection of biomolecules is highly desirable if the efficient
ECL emitters are soluble in water so that ECL immunoassay can be performed in
aqueous buffer media. This is because aqueous media generally is considered to be safer,
greener, and more ecofriendly than organic solvents. Also, organic media are not
compatible with commercial ECL instruments. Moreover, most in-vitro and in-vivo
studies are performed in aqueous buffer conditions. Among the three studied ECL
emitters in Chapter II, 9,10-diphenylanthracene (DPA) and rubrene (RUB) are water
insoluble, whereas Ru(bpy)3Cl2 is soluble in both aqueous and organic media. A wide
range of publications on ECL detection in aqueous media utilize Ru(bpy)32+ and its
derivatives241-253 as well as quantum dots (QDs)254-267 as ECL labels. However, there has
been no any report on usage of water soluble derivatives of efficient ECL emitters of
DPA and RUB for ECL detection purposes in aqueous systems. Thus, it is important to
synthesize their water-soluble derivatives so that all the three emitters could be used for
spectral separation based multiplexing detection of analytes in aqueous media.
Previously,268,269 9,10-diphenylanthracene-2-sulfonate has been shown to produce weak
ECL with anodic coreactant tri-n-propylamine (TPrA) and cathodic coreactant persulfate
in acetonitrile–water (1:1 v/v) mixture media.
This chapter presents the synthesis, electrochemistry and anodic coreactant (i.e.,
TPrA and 2-(dibultylamino)ethanol (DBAE)) ECL studies of water soluble sulfonated
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9,10-diphenylanthracene (DPAS) and sulfonated rubrene (SRUB). ECL enhancement
with nitrate was demonstrated. The direct electron paramagnetic resonance (EPR)
spectroscopic evidence of nitrate radical was obtained, which further supported the
proposed ECL enhancement mechanism.
3.2 Experimental Section
3.2.1 Chemicals
Rubrene (RUB, ≥99%), tri-n- propylamine (TPrA, 99+%), 2(dibutylamino)ethanol (DBAE, 99%), sodium phosphate monobasic monohydrate
(NaH2PO4 • H2O, 99%), nitrobenzene, potassium nitrate (KNO3, 98%), lithium nitrate
(KNO3, 98%), CDCl3 (chloroform-d, 99.6% atoms D and 0.3% v/v TMS) and
hydrochloric acid (HCl, 37.5%) were obtained from Sigma-Aldrich. Fuming sulfuric acid
was from Acros Organics. Dioxane, methylene dichloride, and ethylene dichloride were
purchased from Thermo Fisher Scientific. Acetonitrile (MeCN, 99.93+%, HPLC grade)
was from MP Biomedicals. Sodium nitrate (NaNO3) and ammonium nitrate (NH4NO3)
were purchased from Baker Chemical Co. Methanol (spectroanalyzed grade) and 9,10diphenylanthracene (DPA, 98%) were obtained from Fluka. 2,2-diphenyl-1picrylhydrazyl 5,5-dimethyl-1-pyrroline N-oxide (DMPO) was received from Cayman
Chemical. All chemicals were used as received, unless otherwise stated.
3.2.2 Apparatus and methods
All electrochemical and ECL experiments were performed with a CHI 660A
electrochemical workstation (CH Instruments, Austin, TX) coupled with a
photomultiplier tube (PMT) (Hamamatsu R928, Japan) installed in a light tight black box
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as shown in Figure 3.1. To prevent from external background light interferences, the
electrochemical cell with testing solution was placed inside the light tight box that
covered with a black blanket.113,270 To supply a voltage of -700 V to the PMT, a model
472A Brandenburg PMT power supply (England) was used. A highly sensitive Keithley
6514 electrometer (Keithley, Cleveland, OH) was used to detect the photocurrent from
the testing sample and converts to voltage (± 2.0 V).

Figure 3.1 Homemade ECL instrument setup.
Note: The ECL setup consists of (A) potentiostat, (B) PMT, (C) light tight box with PMT installed, (D) PMT power supply, and (E)
electrometer.

For recording ECL spectra, a workstation from Princeton Instrument (Acton, MA)
comprising (A) a Spec-10:400B/LN-eXcelon digital charge coupled device (CCD)
camera system cooled to -120 °C with liquid nitrogen, (B) ST 133B controller, and (C)
Acton SP-2156 imaging spectrograph was used. The system was controlled and data were
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collected and displayed via “WinSpec/32” software. Electrochemical and ECL signals
were generated with a model 173 potentiostat/galvanostat coupled with a model 175
universal programmer from Princeton Applied Research (Oak Ridge, TN). ECL
emissions at the Pt working electrode were carried over by an optical fiber to the CCD
detector through a 1.5 mm slit. Figure 3.2 shows a photograph of the above CCD based
ECL spectral instrument.

Figure 3.2 Liquid nitrogen cooled CCD camera-based ECL spectral instrument setup.
Note: The setup consists of (A) CCD Camera, (B) monochromator, (C) CCD camera controller, (D) three-electrode electrochemical
cell, (E) light tight black box, (F) computer, and (G) potentiostat/galvanostat.

Diamond crystal attenuated total reflection Fourier transform infrared (ATRFTIR) experiments were performed with a Nicolet Nexus 470 FTIR spectrometer
(Thermo Electron Corp., Madison, WI.). A pinch of crystalline precursors (RUB and
DPA) and synthesized dried solid products (DPAS and SRUB) were used to collect FTIR
spectra.
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1

H NMR spectroscopic experiments were performed using Bruker 400 MHz

NMR spectrometer using a concentration of 5.0 mg/mL in CDCl3.
Mass spectrometry experiments were performed on a Thermo-Finnigan LXQ
electro-spray ionization (ESI)-ion trap mass spectrometer using negative ion mode with a
concentration of 0.1 mg/mL and a flow rate of 100 µL/min in MeCN/H2O (50:50, v/v)
mixed solvent systems.
Electron paramagnetic resonance (EPR) spectroscopy was performed with a
Bruker EMX microX EPR spectrometer equipped with an ER 4119HS standard
cylindrical resonator (Bruker BioSpin Corp.). A resonant frequency of 19.89 GHz, a
modulation frequency of 100 kHz, and a microwave power of 20 mW were used. Precalibration of the EPR instrument was done using the manufacturer’s 2,2-diphenyl-1picrylhydrazyl (DPPH), 1, 3-bis diphenylene-2-phenyl allyl (BDPA), and weak pitch
standard calibration samples. Nitrate radicals (NO3•) were produced in situ with UV
irradiation from a Bruker illumination accessory using 0.10 M KNO3 in the presence of
0.20 M DMPO spin trap agent in aqueous media. Experimentally, the mixture solution
was filled into a standard glass capillary (10 cm long, 2/1.2 OD/ID (mm), World
Precision Instruments, Inc., Sarasota, FL) to a height of ~4 cm and sealed with
“permanent avery glue stic” (Office Depot, Hattiesburg, MS) at the bottom to prevent any
leakage of the sample. This capillary was then placed in a regular quartz EPR tube
(Wilmad Lab Glass) for spectra acquisition. The experimentally obtained EPR spectra
were simulated using PEST Winsim Software (National Institute of Environmental
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Health Sciences, National Institute of Health, Research Triangle Park, NC) for
calculating hyperfine coupling constants.
3.3 Synthesis
3.3.1 Synthesis of water soluble analogue of DPA — Sodium-9,10diphenylanthracene sulfonate (SDPAS)
DPAS was synthesized as reported in the literature269,271-273,274,275 with some
modifications. Briefly, 1.00 g (3.0 mmol) of 9,10-diphenylanthracene (DPA) was
dissolved in 7.0 mL nitrobenzene to form a clear yellow solution, to which excess fuming
sulfuric acid (500.0 μL) was added slowly over a period of five minutes. The reaction
was allowed to occur for 36 h under stirring before a volume of 200.0 mL water was
added. The mixture was separated into two phases — the aqueous phase on the top and
the organic phase on the bottom as nitrobenzene (specific density 1.20 g/mL) was heavier
than water. The aqueous phase was separated from the organic phase with a separatory
funnel, adjusted to pH 7.0 with 10.0 M NaOH, and heated to evaporate the solvent until
~10 mL. 300.0 mL of methanol was subsequently added to the above concentrated
aqueous phase that immediately turned into white slurry (i.e., unreacted DPA). The
filtered methanol solution was concentrated by distillation, yielding ~0.35 g (or ~0.85 g
in the second batch of synthesis) of crude sulfonated DPA (e.g., SDPAS, light yellow
solid).
The crude product was purified by ion-exchange column chromatography using
Dowex 1×2-100 ion-exchange resin (50-100 dry mesh; 3×1 cm) and eluted with a
gradient of 0 to 0.50 M HCl in methanol. Experimentally, the crude yellow product was
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re-dissolved in 10.0 mL of methanol with stirring and sonication. The supernatant was
applied to the ion-exchange column and eluted with (1) 5.0 mL methanol, (2) 5.0 mL of
0.25 M HCl in methanol, and (3) 5.0 mL of 0.50 M HCl in methanol. Fractions from the
last two elution steps were collected and placed in a refrigerator overnight. The
precipitates were transferred to a glass petri dish covered with a piece of filter paper and
air-dried for several days under ambient conditions. Finally, ~45 mg (~3% yield) of light
yellow-green DPAS was scraped from the petri dish with a razor blade. Theoretically,
~1.53 g of the final product should be obtained. The low yield in this synthesis could be
due to (1) low efficiency of sulfonation reaction, and (2) the loss of the product during
the ion-exchange purification process. In the latter case, it might be a good idea to collect
all materials after vaporizing the fractions from the last two elution steps, because
experimentally, no any precipitate was seen at 4 ºC from the fraction of pure methanol
elution (i.e., the first elution step), indicating that the later fractions should essentially
contain pure products. Scheme 3.1 illustrates the synthesis of SDPAS.

Scheme 3.1 Synthesis of SDPAS using the sulfonation of DPA.
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3.3.2 Synthesis of water soluble sulfonated rubrene (SRUB)
SRUB was synthesized as reported in the literature127,276 with some modifications.
Briefly, 1.00 g of rubrene (RUB, 1.8 mmol) was dissolved in a mixed solvent system
consisting of 80.0 mL of 1,4-dioxane, 80.0 mL of ethylene dichloride, and 40.0 mL of
methylene dichloride (2:2:1 in v/v) to form a clear red solution. Excess fuming sulfuric
acid (500.0 μL) was added to the above solution slowly over a period of five minutes.
The reaction media was stirred for 36 h followed by adding 200.0 mL of water into the
mixture, which produced two separate phases with aqueous phase containing the product
on the top and the organic layer on the bottom due to density difference. The aqueous
layer was then collected with a separatory funnel and neutralized with 10.0 M NaOH.
Solution evaporation via heating was undertaken until ~10 mL of concentrated solution
was obtained. Subsequently, 300.0 mL of methanol was added, turning the solution to be
white slurry. The filtered methanol solution was finally concentrated by distillation,
yielding 180.0 mg of SRUB product (light red crystalline, ~13.04% yield). The synthetic
steps are outlined in Scheme 3.2.
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Scheme 3.2 Synthesis of SRUB using the sulfonation of RUB.

3.4 Results and Discussion
3.4.1 Structural characterization and elucidation
Figure 3.3 shows the Fourier transform infrared (FTIR) spectra of pure precursors
(DPA and RUB) along with their sulfonated products (DPAS and SRUB). The IR peaks
between 1000-1400 cm-1 correspond to sulfur-oxygen stretching vibrations. More
specifically, the IR bands at positions ~1156 cm–1, ~1127 cm–1, ~1040 cm–1, and ~1006
cm–1 all account for the -SO3 stretching vibrations of the sulfonate group277-280 from the
sulfonated products, providing solid proof of sulfonation during the synthesis of DPAS
(Figure 3.3 A) and SRUB (Figure 3.3B). The band at ~1400 cm-1 is due to the symmetric
and asymmetric stretching vibrations of O=S=O of the sulfonate group of the sulfonated
products.280 The broad peak between 3000-3500 cm-1 in Figures 3.3A and B account for
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the -OH stretching, possibly from a trace amount of water or MeOH used in the synthetic
steps. The shoulder just above 3000 cm-1 in both the Figures 3.3A and B was assigned for
Ar-H stretching both the precursors and the sulfonated products containing benzene
moieties (for instance DPA and DPAS contain 5 benzene rings while RUB and SRUB
contains 8 benzene rings).
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Figure 3.3 FTIR spectra of (A) DPA and DPAS, and (B) RUB and SRUB.
Note: The arrows marked are signature bands for -SO2 and SO3 stretching vibrations.

The evidence of successful sulfonation of DPA is also witnessed by electro-spray
ionization mass spectrometry (ESI-MS) (Figure 3.4), where the m/z peak at 409 in
negative mode scan corresponds to the molecular mass of DPAS having molecular mass
of its precursor DPA plus one sulfonated group. Moreover, no ESI-MS peak for the
precursor DPA (molecular weight = 330.45 g/mol) was seen, suggesting the high purity
of the final DPAS product.
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Figure 3.4 ESI-MS data of DPAS.
The ESI-MS data were obtained with 0.1 mg/mL DPAS in MeCN: H2O (50:50, v/v) at a flow rate of 100 µL/min in negative mode
scan.

Proton nuclear magnetic resonance (1H-NMR) spectroscopy data (Figure 3.5A)
revealed a total of 18 protons upon integration when the precursor DPA was subjected to
1

H-NMR spectroscopy (molecular formula of DPA = C22H18). On the other hand, the

integration of the 1H-NMR of sulfonated DPAS data showed a total of 17 protons (Figure
3.5B), indicating that DPAS (molecular formula = C22H17SO3H) contains only one
sulfonated group. This finding is consistent with the MS data described above. Similarly,
the integration of all the NMR peaks from 1H -NMR data of rubrene (RUB) (molecular
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formula = C42H28) summed to a total of 28 protons (Figure 3.5C). On the other hand, the
1

H-NMR sulfonated rubrene (SRUB) data upon integration of all NMR peaks gave a total

of 26 protons (Figure 3.5D), confirming that 2 protons were replaced by two sulfonated
groups resulting in the synthesis of disubstituted sulfonated rubrene, i.e. the final product
SRUB (molecular formula = C42H26S2O6H2).
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D

Figure 3.5 1H-NMR spectroscopy data of (A) DPA, and (B) DPAS, (C) RUB, and (D)
SRUB.
Note: 1H-NMR spectroscopy experiments were performed with a concentration 5 mg/mL in CDCl3.

3.4.2 Electrochemistry of DPAS and SRUB
The solubility of sulfonated DPA (DPAS) and sulfonated rubrene (SRUB) was
very low (~10 µM) in sodium phosphate buffer (PBS, pH 7.5). To acquire good CV
signals, DPAS and SRUB were dissolved in 95% PBS (pH 7.5)-5% MeCN (v/v) with an
estimated concentration of 50 µM (saturated). As shown in Figure 3.6A, DPAS
irreversibly oxidizes at ~1.17 V vs Ag/AgCl (3.0 M KCl) at a glassy carbon electrode
(GCE), indicating that the DPAS radical cation is not sufficiently stable in the reaction
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media within the time scale of the experiment. To better probe the electrochemical
behavior of DPAS, differential pulse voltammetry (DPV) was applied, in which, DPAS
oxidizes with a peak potential of 1.07 V vs Ag/AgCl (Figure 3.6B). The pre-wave
appeared in DPV could result from the adsorption of DPAS on GCE.
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Figure 3.6 (A) CVs, and (B) DPVs of DPAS in aqueous media.
Note: In Figure 3.6A, (a) CV of the background (0.10 M PBS (pH 7.5 with 5% MeCN (v/v)), (b) CV of ~50 μM DPAS in 0.10 M PBS
(pH 7.5) with 5% MeCN (v/v), and (c) CV after background subtraction. In Figure 3.6B, (a) background (0.10 M PBS (pH 7.5 with
5% MeCN (v/v)), (b) DPV of 50 μM DPAS in 0.10 M PBS (pH 7.5) with 5% MeCN (v/v). Both CV and DPV experiments were
performed using a 3-mm GCE.at (A) a scan rate of 100 mV/s and (B) pulse width = 0.2 s, sample width = 0.016 s, and pulse period =
0.5 s.

Similarly, the irreversible oxidation of SRUB occurs at ~0.80 V vs Ag/AgCl on
CV and ~0.86 V vs Ag/AgCl on DPV as shown in Figure 3.7A and Figure 3.7B,
respectively. The oxidation potentials for sulfonated DPA and RUB are close to their
predecessors as discussed in Table 2.1 of Chapter II, although different solvents and
electrodes were used.
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Figure 3.7 (A) CVs, and (B) DPVs of SRUB in aqueous media.
Note: In Figure 3.7A, (a) CV of the background (0.10 M PBS (pH 7.5 with 5% MeCN (v/v)), (b) CV of ~50 μM SRUB in 0.10 M PBS
(pH 7.5) with 5% MeCN (v/v), and (c) CV after background subtraction. In Figure 3.7B, (a) background (0.10 M PBS (pH 7.5 with
5% MeCN (v/v)), (b) DPV of 50 μM SRUB in 0.10 M PBS (pH 7.5) with 5% MeCN (v/v). Both CV and DPV experiments were
performed using a 3-mm GCE.at (A) a scan rate of 100 mV/s and (B) pulse width = 0.2 s, sample width = 0.016 s, and pulse period =
0.5 s.

3.4.3 Effect of ECL coreactant and electrode material on ECL production
Various anodic and cathodic ECL coreactants were tested to find out the most
suitable or favorable ECL coreactant for DAPS and SRUB. As only extremely weak ECL
was observed from cathodic coreactant persulfate, the following discussion focuses on
anodic ECL coreactants DBAE and TPrA. As shown in Figure 3.8, upon the anodic
potential scanning, ECL is produced from the DPAS/DBAE system (Figure 3.8A) and the

87

DPAS/TPrA system (Figure 3.8B) at all three tested electrodes, namely, Pt, Au, and
glassy carbon (GC) electrode.
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Figure 3.8 Effect of electrode material on the ECL intensity of (A) DPAS/DBAE and (B)
DPAS/TPrA system.
Note: ECL was generated with DPAS using (A) 25 mM DBAE and (B) 25 mM TPrA. The concentration of DPAS was 7.5 μM at
different electrodes (indicted in the Figure) at a scan rate of 100 mV/s.

Similar behavior was observed for the SRUB/DBAE system (Figure 3.9A) and
the SRUB/TPrA system (Figure 3.9B).
Several features are noticed: (1) ECL generated from DPAS occurs at a more
positive potential than SRUB does, (2) for the same ECL emitter (DPAS or SRUB),
much stronger ECL signals are produced when DBAE rather than TPrA is used as the
coreactant, (3) relative weak ECL signals are produced from DPAS as compared with
SRUB, and (4) electrode materials strongly affect the ECL behavior.
89

A
10
2

iECL (nA/mm )

(a) Pt
(b) GC
(c) Au

a

5
c
b
0
2.0

1.5

1.0

0.5

0.0

E (V vs. Ag/AgCl)

0.8

B
a

2

iECL (nA/mm )

0.6

(a) Au
(b) GC
(c) Pt

0.4

0.2

c

b

0.0
2.0

1.5

1.0

0.5

0.0

E (V vs. Ag/AgCl)

Figure 3.9 Effect of electrode material on the ECL intensity of (A) SRUB-DBAE and (B)
SRUB-TPrA system.
Note: ECL was generated with SRUB using (A) 25 mM DBAE, and (B) 25 mM TPrA. The concentration of SRUB was 7.5 μM at
different electrodes (indicted in Figure) at a scan rate of 100 mV/s.
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The striking features that summarize DPAS system are enlisted as: (1) ECL
generated from DPAS occurs at a more positive potential than SRUB does, (2) for the
same ECL emitter (DPAS or SRUB), much stronger ECL signals are produced when
DBAE rather than TPrA is used as the coreactant, (3) relative weak ECL signals are
produced from DPAS as compared with SRUB, and (4) electrode materials strongly
affect the ECL behavior. These observations can be explained with the ECL mechanism
shown in Scheme 3.3, where DBAE could be replaced with TPrA as both coreactants
share the similar reaction pathways.30
DBAE − e → DBAE •+

(electrochemical oxidation)

(3.1)

R − e → R•+

(electrochemical oxidation)

(3.2)

DBAE •+ − H + → DBAE •

(deprotonation)

(3.3)

R•+ + DBAE • → R∗

(chemical reduction)

(3.4)

R + DBAE • → R•−

(chemical reduction)

(3.5)

R•+ + R•− → R∗ + R

(excited state formation)

(3.6)

R∗ → R + hv

(ECL generation)

(3.7)

(R = DPAS or SRUB, and DBAE = (CH3CH2CH2CH2)2NCH2CH2OH)
Scheme 3.3 ECL mechanism with DBAE as an anodic ECL coreactant.
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To generate ECL, both coreactant and ECL emitter must be electrochemically
oxidized (Equations 3.1-3.2). Because the oxidation of coreactant often occurs at a less
positive potential region than that of ECL emitter, the onset potential of ECL generation
is essentially determined by the oxidation potential of the emitter. As discussed earlier in
Figures 3.6 and 3.7, DPAS oxidizes at ~1.1 V vs Ag/AgCl but SRUB at ~0.8 V vs
Ag/AgCl, it is expected that the ECL system of DPAS appears at a more positive
potential region. The ECL-CV profiles shown in Figure 3.10 further supports the above
discussion. In this Figure 3.10, 25 mM of DBAE and 7.5μM of DPAS are used, hence the
CV responses should be predominated by the oxidation of DBAE. The ECL intensity is
also directly proportional to the amount of the coreactant oxidized; the more coreactant
oxidation is (Equation 3.1), the freer radicals of DBAE• (or TPrA•) forms (Equation 3.3),
the more excited state species R* is produced (Equation 3.5), thus the stronger the ECL
intensity (Equation 3.7). Electrochemical oxidation of DBAE has shown to be easier than
that of TPrA (see Figure 2.5 in Chapter II for more details). As a result, the DBAE
system gives stronger ECL signals than the TPrA system. To make Equation 3.5 occur,
the reducing power of the free radical, i.e., the reduction potential of DBAE• (or TPrA•),
must be more negative than that of R•− . As shown in Table 2.1 of Chapter II, DPA has a
much negative reduction potential (-2.24 V vs SCE) than that of RUB (-1.79 V vs SCE)
in MeCN, it is likely that the reduction potential of DPAS in aqueous solution is much
negative than that of SRUB. In other words, the chance of Equation 3.5 to occur is more
likely for SRUB as compared with DPAS. Therefore, SRUB displays stronger ECL than
DPAS does.
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Figure 3.10 ECL-CV profiles of the DPAS-DBAE system.
Note: ECL-CV profiles were obtained with 7.5 µM DPAS-25 mM DBAE at a 2-mm Pt electrode sweeping at 100 mV/s in 0.10 M
PBS (pH 7.5).

Figures 3.11 shows the effect of coreactant concentration and electrode material
on ECL intensity of the DPAS/DBAE system (Figures 3.11A and B) and the SRUB/TPrA
system (Figure 3.11C and D). It is evident that for DBAE coreactant, the optimal
concentration for both DPAS and SRUB ECL production is around 25 mM (Figures
3.11A and C). This could be because DBAE acts as both ECL coreactant and ECL
quencher. For TPrA, however, the higher the concentration is, the higher the ECL signal
is generated (Figures 3.11B and D). This is consistent with the fact that the higher the
concentration of TPrA, the more TPrA+• and TPrA• species can be produced, therefore
the stronger the ECL (Scheme 3.3). As for the working electrode, Pt is clearly the most
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favorable electrode for the DPAS/DBAE and SRUB/DBAE systems (Figures 3.11A and
C), whereas mixed results are found when TPrA is used (Figures 3.11B and D). The
combination of electrochemical oxidations of both ECL emitter and coreactant at a given
electrode has probably played certain roles in determining the effect of the electrode
material on ECL production.
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Figure 3.11 Effect of coreactant concentration and electrode material on ECL intensity.
Note: ECL measurements were conducted in 0.10 M PBS (pH 7.5) containing 7.5 µM ECL emitter of (A) and (B) DPAS, or (C) and
(D) SRUB using coreactant of (A) and (C) DBAE, or (C) and (D) TPrA with a scan rate of 100 mV/s. Each point in the figure was an
average result of three replicated tests.

3.4.4 ECL enhancement with nitrate ions
The ECL signals generated from the water soluble DPAS/DBAE and
SRUB/DBAE systems were relatively weak. Inspired by the study published previously
from this research group,281 where ECL determination of hexamethylene triperoxide
diamine explosives was enhanced by silver nitrate in MeCN, we tested the effect of
nitrate ions on the ECL production of the DPAS/DBAE and SRUB/DBAE systems. As
shown in Figures 3.12, after addition of 10.0 mM NaNO3 to the above two systems, the
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ECL peak intensity is increased by a factor of 13 (Figure 3.12A) and 11 (Figure 3.12B),
respectively. CV responses indicate that much higher oxidation currents on the forward
scan are seen for the DPA/DBAE-NaNO3 system as compared with the DPA/DBAE
system alone (Figure 3.12A). On the other hand, however, only moderate increase in the
forward oxidation currents is observed for the SRUB/DBAE-NaNO3 system (Figure
3.12B). Moreover, CV responses are clearly shown to be affected by the ECL emitter
present in the solution. This could be contributed partially to the electrocatalytic
processes shown in Equations 3.8-3.9, where DPAS•+ produced electrochemically at the
electrode oxidizes DBAE chemically in the solution, resulting in regeneration of DPAS.
DPAS – e → DPAS•+ (heterogeneous electrochemical oxidation)

(3.8)

DPAS•+ + DBAE →DPAS + DBAE•+ (homogeneous chemical reaction)

(3.9)

The above explanation is consistent with the oxidation peak potential of ~1.17 V
for DPAS (Figure 3.6A) and ~0.9 V vs Ag/AgCl for DBAE, as well as with the small
oxidation wave appeared at around 1.28 V vs Ag/AgCl on the forward scan of the CV in
Figure 3.12A. Otherwise, the electrochemical oxidation of 7.5 M DPAS would not be
seen in the presence of 25.0 mM DBAE. In the case of SRUB, the oxidation potential of
~0.86 V vs Ag/AgCl (Figure 3.7A) for SRUB•+ is not sufficiently positive enough to
oxidize DBAE. The presence of SRUB seems also to inhibitate the electro-oxidation of
DBAE and nitrate ions, as in these cases, delayed and ill-defined oxidation processes are
evident (Figure 3.12B) as compared with CVs in Figure 3.12A. Physical adsorption of
SRUB on Pt could be responsible for this behavior.
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Figure 3.12 Effect of nitrate ions on ECL from (A) DPAS/DBAE, and (B) SRUB/DBAE.
Note: CV-ECL experiments were conducted in 0.10 M PBS (pH 7.5) containing (A) 7.5 µM SRUB-25.0 mM DBAE and (B) 7.5 µM
DPAS-25.0 mM DBAE in the absence and presence of 10.0 mM NaNO3. A 2-mm diameter Pt and a scan rate of 100 mV/s were used.

Close inspection of Figure 3.13 reveals that the enhanced ECL responses by
nitrate ion have a less positive onset potential than that from a redox media without added
NaNO3. Besides, the enhancement starts at ~0.80 V vs Ag/AgCl for the DPAS/DBAENaNO3 system and ~1.00 V vs Ag/AgCl for the SRUB/DBAE-NaNO3 system. These two
potential values are even less positive than the onset oxidation potential of NaNO3, i.e.,
~1.05 V vs Ag/AgCl (Figure 3.13a). As a result, the pre-enhancement of ECL is probably
ascribed to the pre-oxidation of the ECL emitter and coreactant, which is facilitated by
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the added NaNO3. Previous studies using FTIR spectroscopy282 and indirect radiotracer
method283 have confirmed the adsorption of NO3- ions on Pt and other metal surfaces.
During anodic potential scanning, such adsorption could prevent the formation of
platinum oxides (e.g., PtO and PtO2),284 therefore promoting the oxidation of
electroactive species. As shown in Figure 3.13b, the onset oxidation potential of DBAE is
shifted from 1.10 V to 0.75 V vs Ag/AgCl after the addition of NaNO3.
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Figure 3.13 CVs of (a) NaNO3, (b) DBAE-NaNO3, and (c) DBAE.
Note: (a) CV measurements were conducted in 0.10 M PBS (pH 7.5) containing (a) 10 mM NaNO 3, (b) 25.0 mM DBAE and 10.0 mM
NaNO3, and (c) 25.0 mM DBAE at a 2-mm diameter Pt electrode with a scan rate of 100 mV/s.
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The electrochemical oxidation of NaNO3 starts at ~1.05 V with an anodic peak
potential of ~1.65 V vs Ag/AgCl (Figure 3.13c), which matches the ECL generation
window of the DPAS/DBAE as well as SRUB/DBAE system. As will be discussed in
detail later, the ECL enhancement originates from the electrochemical oxidation of nitrate
ions.
Figure 3.14 illustrates the effect of [NaNO3] on the ECL enhancement. With the
increase of [NaNO3] from 0 to 8.0 mM, the ECL intensity for the DPAS/DBAE as well as
the SRUB/DBAE system increases gradually. After [NaNO3] reaches 9.0 mM, the
enhancement levels off. Notice also that the effect of ECL enhancement by NaNO3 is
more significant towards the SRUB/DBAE system than the DPAS/DBAE system.
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Figure 3.14 Effect of [NaNO3] on the ECL enhancement of (a) SRUB/DBAE and (b)
DPAS/DBAE system.
Note: ECL intensity at peak was used and other experimental conditions were the same as listed in Figure 3.9.

The above remarkable ECL enhancement by NaNO3 is further testified by the
data shown in Figure 3.15, where ECL signals are acquired with the spectral ECL
instrument reposted in Chapter II rather than a highly sensitive photodetector
photomultiplier tube (PMT). With the addition of NaNO3 into the mixed (DPASRu(bpy)32+)/DBAE system, quantification of originally undetectable ECL signals is
realized.
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Figure 3.15 Demonstration of ECL enhancement by NaNO3 using the mixed (DPASRu(bpy)32+)/DBAE system.
Note: (a) ECL spectra of [DPAS] from 2.5 to 7.5 µM, mixed with a constant [Ru(bpy) 32+] of 1.0 µM, and (b) ECL spectra obtained
after addition of 10.0 mM NaNO3 to solutions described in (a). All data were collected from the homemade spectral ECL instrument
with a linear sweep voltammetry from 0 to 2.0 V vs Ag/AgCl at 100 mV/s.

Previously,281 AgNO3 was used as an ECL enhancing agent in MeCN, and both
Ag+ and NO3- ions were found to be responsible for ECL enhancement. In the present
study, however, AgNO3 cannot be used because Ag+ ion can react with phosphate buffer
to form silver precipitates. To verify if the cations of nitrate salts would play any role
during the process of ECL enhancement, nitrate salts with various cations M (M = Li+,
Na+, K+, and NH4+) were added to a well-understood Ru(bpy)32+/DBAE system. The
resultant ECL profiles are shown in Figure 3.16, suggesting that nitrate ion is solely
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responsible for the ECL enhancement. Compared with data shown in Figure 3.12, ECL
profiles of the Ru(bpy)32+/DBAE-MNO3 system are extended to a much broad potential
range with a clear pre-enhancement feature. This broadening effect is consistent with the
electrochemical oxidation behavior of NaNO3 (Figure 3.13a), and is probably an
indication of R•– stability in the solution (see Scheme 3.4 for details). In other words, the
anion radicals of the three tested ECL emitters follow a stability order of Ru(bpy)3 + >
SRUB•– > DPAS•–.
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Figure 3.16 Effect of different nitrate salts on the ECL enhancement of the
Ru(bpy)32+/DBAE system.
Note: ECL measurements were conducted in 0.10 M PBS buffer (pH 7.5) containing 7.5 μM Ru(bpy) 32+ and 25.0 mM DBAE in in the
absence and presence of 10.0 mM of LiNO3, KNO3, NH4NO3, and NaNO3 at a 2-mm diameter Pt electrode with a scan rate 100 mV/s.
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On the basis of the data presented above and previous studies,281,285-287 it is
believed that the significant ECL enhancement of the R/DBAE system with nitrate ions is
associate with the chemical oxidation reactions of nitrate free radical (NO3•) generated
electrochemically (Equation 3.10) with the ECL emitter R (Equation 3.11), coreactant
DBAE (Equation 3.12), and R•– (Equation 3.13), forming species that are crucial for ECL
emissions. The NO3•/NO3- couple has an estimated standard redox potential of ~1.80 V vs
Ag/AgCl,39 which is consistent with the oxidation peak potential of 1.65 V vs Ag/AgCl
for NaNO3 in aqueous media (Figure 3.13a) and that of ~1.63-1.9 V vs Ag/AgCl for NO3in MeCN.285-287 Scheme 3.4 is the proposed ECL mechanism of the R/DBAE-NO3system using DBAE as an anodic ECL coreactant and NO3- as an ECL enhancing agent,
where Equations 3.10-3.13 are highlighted and contributed to the ECL enhancement.
DBAE − e → DBAE •+

(electrochemical oxidation)

(3.1)

R − e → R•+

(electrochemical oxidation)

(3.2)

DBAE •+ − H + → DBAE •

(deprotonation)

(3.3)

R•+ + DBAE • → R∗

(chemical reduction)

(3.4)

R + DBAE • → R•−

(chemical reduction)

(3.5)

•
NO−
3 − e → NO3

(electrochemical oxidation)

(3.10)

R + NO3• → R •+

(chemical oxidation)

(3.11)

NO•3 + DBAE → DBAE •+ (chemical oxidation)

(3.12)
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NO•3 + R•− → R∗

(excited state formation)

(3.13)

R•+ + R•− → R∗ + R

(excited state formation)

(3.6)

R∗ → R + hv

(ECL generation)

(3.7)

(R = DPAS, SRUB, or Ru(bpy)32+, DBAE = (CH3CH2CH2CH2)2NCH2CH2OH)
Scheme 3.4 Proposed ECL mechanism of the R/DBAE-NO3- system using DBAE as an
anodic ECL coreactant and NO3- as an ECL enhancing agent.
3.4.5 Direct EPR Evidence of Nitrate Free Radical (NO3•)
To verify if nitrate free radical exists in the chemical environment similar to the
ECL media, EPR spectroscopy of potassium nitrate was performed in an aqueous
solution. The use of a regular quartz EPR tube is not appropriate because the heating of
the aqueous solution by microwave resulting in the tuning of the EPR instrument to be
difficult. Consequently, a small glass capillary tube was used to hold the test solution.
Although photolysis of nitrate can involve a series of complicated reactions,288-290 both
NO3• and OH• free radicals are expected to form first before they are caught by spin
trapping agent DMPO (Equations 3.14-18). The EPR signals are produced from the
respective stable DMPO/radical adducts, whose chemical structures are shown in Scheme
3.5.
NO3- + hv → (NO3-)*

(3.14)

H2O + hv → (H2O)* → OH• + H•

(3.15)
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(NO3-)* + OH• → NO3• + OH-

(3.16)

DMPO + OH• → DMPO/OH•

(3.17)

DMPO + NO3• → DMPO/NO3•

(3.18)

Scheme 3.5 Formation of DMPO/NO3• and DMPO/OH• adducts.
Figure 3.17 shows the experimental and simulated EPR spectra of aqueous KNO3
mixed with DMPO under UV irradiation. The reason to choose KNO3 instead of NaNO3
was because KNO3 had higher purity than NaNO3, thus potential impurity interfaces to
EPR production were minimized. The experimentally obtained EPR spectra (Figure
3.17a) consist of peaks from two types of DMPO/radical adducts, where peaks labelled
with “*” are from DMPO/OH• radicals and ones with “&” labeling are from DMPO/NO3•
radicals. These assignments are supported by EPR simulations presented in Figures 3.17c
and d, respectively, using Winsim software. Although DMPO/OH• EPR spectra have
been widely reported,288,291-296 no EPR spectra on DMPO/NO3• radicals is found. For
DMPO/OH• simulation, the hyperfine coupling of the unpaired electron with the N
nucleus and H nucleus was considered. The same coupling constants (aN = 14.85 G
and aH = 14.85 G) taken from a previously published paper of this research group on
hydroxyl radical EPR were used.281 For DMPO/NO3• simulation, in addition to the
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coupling between the unpaired electron and the N nucleus (aN = 14.85 G),
contributions from the -H with two possible conformation sites are included.293. These
two sites in chemical exchange should have close hyperfine coupling constants as found
out during the optimization of simulation (aH1 = 13.85 G and aH2 = 13.70 G). The
combination of the above two simulated EPR spectra is illustrated in Figure 3.17b, which
matches well with the experimentally obtained one (Figure 3.17a).
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Figure 3.17 Experimental and simulated EPR spectra for nitrate mixed with DMPO in
water under UV irradiation.
Note: EPR spectra were obtained from UV irradiation of 0.10 M KNO3 with 200 mM 5,5′-dimethyl pyrroline-N-oxide (DMPO as spin
trap) in aqueous media, using a resonant frequency of 9.86 GHz, a modulation frequency of 100 kHz, a microwave power of 2.697
mW, and a time constant of 32 ms. The EPR spectra were the collection of 4 consecutive scans. (a) Experimental, (b) overall
simulation, (c) simulation of DMPO/OH•, and (d) simulation of DMPO/NO3•. The following hyperfine coupling constants were used:
for (c) aN = 14.85 G and aH = 14.85 G, and for (c) a = 14.85 G, aH1 = 13.85 G, and aH2 = 13.70 G.

EPR spectra from solid sodium nitrate irradiated with X or  rays have been
previously reported.297
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3.4.6 ECL Studies of Mixed Systems of DPAS, SRUB, and Ru(bpy)32+
ECL titration study was first undertaken to examine possible interactions between
DPAS and SRUB, whose ECL emissions are at ~ 420 nm and ~ 550 nm, respectively.
Attempts to collect ECL spectra from the binary mixed system of DPAS-SRUB, where
the concentration of SRUB was increased while keeping the concentration of DPAS
constant, were unsuccessful, because concentrations of DPAS and SRUB larger cannot
be larger than 10 μM in sodium phosphate buffer as mentioned in Chapter II. At such low
concentrations, ECL spectra were too weak to be recorded. Upon addition of nitrate (10
mM optimal concentration) to the system, ECL spectra immediately became detectable.
Figure 3.18A shows the ECL spectra of the (DPAS-SRUB)/DBAE-NO3- system with a
constant concentration of DPAS at 2.50 μM mixed with different concentrations of
SRUB. With the increase of SRUB concentration, ECL intensity at ~550 nm for SRUB
emissions increases as expected. Meanwhile, the ECL intensity at ~420 nm for DPAS
remains essentially unchanged. The inset in Figure 3.18A displays the linear responses of
ECL intensities with the increase in the concentration of SRUB. This finding suggests
that the energy transfer interactions between the two emitters are insignificant at low
concentrations, which is different from the cases in Chapter II when higher
concentrations of emitters were used.
Figure 3.18B shows the ECL spectral data for the mixed (DPASRu(bpy)32+)/DBAE-NaNO3 system, where ECL emissions from DPAS and Ru(bpy)32+
increase with the increase of Ru(bpy)32+ concentration due to the energy transfer
interactions as described in Chapter II.
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Figure 3.18 ECL spectra of (A) (DPAS-SRUB) /DBAE-NaNO3 and (B) (DPASRu(bpy)32+)/DBAE-NaNO3.
Note: 25.0 mM DBAE as ECL coreactant and 10.0 mM NaNO3 as ECL enhancing agent were used. All ECL-intensity measurements
were carried out in 0.10 M sodium phosphate buffer (pH 7.5). A 2-mm diameter Pt electrode and a scan rate of 100 mV/s were
applied. LN CCD camera was used as detector.

Figure 3.19A shows the ECL spectra of mixed DPAS-SRUB-Ru(bpy)32+ system
in the presence of 25.0 mM DBAE and 10.0 mM NaNO3. With the increase of Ru(bpy)32+
concentration, ECL intensity of DPAS increases slightly, and the ECL for SRUB remains
unchanged as displayed in the inset after spectral deconvolution (see Sections 2.3.5 and
2.3.6 of Chapter II for detail). Figure 3.19B shows the effect of SRUB concentration
changes on ECL signal changes of DPAS and Ru(bpy)32+. In this case, with the increase
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of SRUB concentration, ECL signal changes for both DPAS and Ru(bpy)32+ increase due
to energy transfer interactions.
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Figure 3.19 ECL spectra (DPAS-SRUB-Ru(bpy)32+)-NaNO3/DBAE with the
concentration change of (A) Ru(bpy)32+) and (B) SRUB.
Note: Experiments were carried out with 10.0 mM NaNO3 as ECL enhancing agent.in 0.10 M sodium phosphate buffer, pH 7.5. A 2mm diameter Pt electrode and a scan rate of 100 mV/s were applied. LN CCD camera was used as detector.

3.5 Conclusion
Water soluble analogues of DPA and RUB, i.e., DPAS and SRUB, were
synthesized and characterized by electrochemical and ECL studies. The CV and ECL
behavior of both DPAS and SRUB was very similar (in terms of redox potential, ECL
emission wavelength, ECL generation potential window, etc.) to that of their precursors
DPA and RUB. The weak ECL emissions of both DPAS and SRUB with DBAE as
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anodic ECL coreactant were enhanced with nitrate salt. More than 10 times enhancement
in ECL intensity was found for all three ECL emitters when 10.0 mM NaNO3 was used.
This effect was believed to be ascribed to the formation of NO3• free radical, which was
confirmed by EPR spectra obtained from solution phase KNO3 under UV irradiation in
the presence of DMPO as spin trapping agent. Finally, ECL responses from mixed ECL
emitter systems were studied, where energy transfer interactions occurred, although such
effects may be insignificant at a much lower concentration range.
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CHAPTER IV – DIRECT ELECTRON PARAMAGNETIC RESONANCE EVIDENCE
OF CATHODIC ECL COREACTANT INTERMEDIATES OF BENZOYL PEROXIDE
AND AMMONIUM PERSULFATE
4.1 Introduction
Coreactant electrogenerated chemiluminescence (ECL) is a type of ECL that is
generated from an ECL emitter (R) mixed with a deliberately added chemical termed
“coreactant” (C) upon anodic or cathodic potential scanning.72,81 For anodic coreactant
ECL (Scheme 4.1), C along with R is first electrochemically oxidized to form C•+ and
R•+, which is immediately followed by a homogeneous chemical dissociation that
converts C•+ to a strongly reducing agent C• free radical. C• then chemically reduces R to
R•–. Finally, R•+ annihilates with R•– to produce the excited state R* that emits light.
C – e → C•+

(electrochemical oxidation)

(4.1)

R – e → R•+

(electrochemical oxidation)

(4.2)

C•+ → C•

(chemical decomposition)

(4.3)

C• + R → R•–

(chemical reduction of R)

(4.4)

R•+ + R•– → R*

(ion annihilation)

(4.5)

R* → R + hv

(ECL emission)

(4.6)

Scheme 4.1 A general ECL mechanism of an anodic ECL system with R served as an
ECL emitter and C as a coreactant.
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On the other hand, for cathodic coreactant ECL (Scheme 4.2), C along with R is
first electrochemically reduced to form C•– and R•–, which is immediately followed by a
homogeneous chemical decomposition reaction that converts C•– to a strongly oxidizing
agent C• free radical. C• then chemically oxidizes R to R•+. Finally, R•+ annihilates with
R•– to produce the excited state R* that emits light.
C + e → C•–

(electrochemical reduction)

(4.7)

R + e → R•–

(electrochemical reduction)

(4.8)

C•+ → C•

(chemical decomposition)

(4.9)

C• + R → R•+

(chemical oxidation of R)

(4.10)

R•+ + R•– → R*

(ion annihilation)

(4.5)

R* → R + hv

(ECL emission)

(4.6)

Scheme 4.2 A general ECL mechanism of a cathodic ECL system with R served as an
ECL emitter and C as a coreactant.
Examples of commonly used R include 9,10-diphenylanthracene (DPA), rubrene
(RUB), Ru(bpy)32+, and their derivatives. Two commonly used anodic coreactants C are
tri-n-propylamine (TPrA) and 2-(dibutylamino)ethanol (DBAE), and benzoyl peroxide
(C6H5COOOCC6H5 or BPO) and persulfate (S2O82-) are examples of two cathodic ECL
coreactants. Coreactant ECL has been well studied and widely used in chemical and
biochemical analysis. The proposed ECL mechanism is also broadly accepted; however,
very limited experimental evidence in the literature that directly show the presence of
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coreactant intermediates (i.e., C•+, C•–, or C•). This is probably because these cation,
anion, or neutral free radicals are short-lived, unstable, and very reactive, which is
supported by the fact that cyclic voltammetric responses of these coreactants only show
irreversible behavior, even at a very fast scan rate (ν = 5000 mV/s).
Given the fact that all aforementioned coreactant intermediates have unpaired
electrons, electron paramagnetic resonance (EPR) spectroscopy or electron spin
resonance (ESR) spectroscopy could be a powerful technique to probe these species. EPR
measures the absorption of electromagnetic radiation with a wavelength in microwave
region (in the order of a few cm) by a sample with unpaired electron under an external
magnetic field. Unlike NMR, where nuclear spins are excited, in EPR the electron spins
are excited. EPR spectra is a display of the first order differentiation or derivative of
absorbance. Experimentally, EPR spectrum is often measured by holding microwave
frequency constant while sweeping the magnetic field, and the power absorbed is
acquired as a function of the applied magnetic field.
EPR has been used to study a variety of reactive oxygen species (ROS) including
peroxides, superoxide, hydroxyl radical, and singlet oxygen as well as reactive nitrogen
species (RNS)298-300. EPR spectroscopy has been applied for online monitoring of species
of environmental concerns,301-305 thermally generated radicals,306 polymers,307 proteomics
and genome-wise expression studies,308 transition-metal proteins (metalloproteins),309-314
bio-medical, clinical and pharmaceutical applications,315-318 DNA-metal complex
interactions, biologically relevant free radicals in cellular, ex vivo, and in vivo
systems.319-322
118

Previously, EPR evidence of TPrA•+, the radical cation intermediate formed after
TPrA oxidation, was reported.216 Reports323,324 on BPO generating BPO• (i.e.,
benzoyloxyl radical C6H5COO•) in solid state are also available. In this chapter, EPR data
of cathodic coreactant intermediates BPO• radical generated from BPO and SO4•– anion
radical generated from persulfate (S2O82-) are presented. The electrochemical and
chemical reaction pathways of generating BPO• from BPO at electrode surface have been
described in Scheme 2.1 in Chapter II. Moreover, BPO yielded the strongest ECL
emission in comparison to TPrA and DBAE when mixed with ECL emitter DPA, RUB,
or Ru(bpy)32+ (Chapter II). BPO and persulfate have similar ECL mechanisms and both
contain common ECL peroxide linkage moiety (-O-O-), allowing one to generate their
intermediates using similar strategy.
4.2 Experimental Section
4.2.1 Chemicals and materials
Benzoyl peroxide (BPO, C14H10O4, 97%) was purchased from Aldrich.
Ammonium persulfate or ammonium peroxydisulfate ((NH4)2S2O8, 98%) was obtained
from Fluka. Hydrazine hydrate (N2H4), acetonitrile (HPLC grade), 5,5-dimethyl-1pyrroline-N-oxide (DMPO, ≥98%) were obtained from Cayman Chemical (Ann arbor,
MI). For measuring organic samples, a thin quartz EPR tube with outer diameter (OD)
4.0 mm, inner diameter (ID) 3.0 mm, wall thickness 0.5 mm, and 250 mm long from
Wilmad Lab Glass (PA) was used. For measuring EPR spectra in water, a standard glass
capillary (100 mm long, 2/0.5, OD/ID (mm), World Precision Instruments, Inc., Sarasota,
FL) was utilized.
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Figure 4.1 Block diagram of EPR instrumentation.
Note: (a) Microwave radiation source (klystrons or gun oscillator), (b) sample cell, (c) d.c. magnetic field and a sweeping circuit for
changing the magnetic field, (d) detection system, and (e) data acquisition.

The block diagram of EPR instrumentation is shown in Figure 4.1.The
experimental setup consists of (a) microwave radiation source (klystrons or gun
oscillator) that provides a power output of about 300 mW holding the frequency constant,
(b) a sample cell placed in the cavity where the microwave is transmitted through
waveguide to convey the wave radiation to the sample, (c) a d.c. magnetic field and a
sweeping circuit for changing the magnetic field., (d) a detection system (basically a
rectifier crystal) for measuring the absorption, and (e) a data acquisition and a phase
sensitive signal processing unit.
4.2.2 EPR parameters and acquisition
EPR spectroscopy was performed with a Bruker EMX microX EPR spectrometer
equipped with an ER 4119HS standard cylindrical resonator (Bruker BioSpin Corp.). Pre120

calibration was done using the manufacturer’s 2,2-diphenyl-1-picrylhydrazyl (DPPH),
1,3-bisdiphenylene-2-phenylallyl (BDPA), and weak pitch standard calibration samples.
Unless otherwise stated, all the EPR measurements were conducted at room temperature
20 ± 2 °C.
4.2.3 Spin labels (traps)
When the free radical or the molecule with unpaired electron is very unstable or
has a very short life (order of nano to pico second), then a spin trap (label) is used. Spin
traps are organic molecules having unpaired electrons. Most common spin traps are the
class of nitrones (Figure 4.2) and have the ability to bind to the molecule (EPR inactive)
and convert them to EPR active forming spin trap/ molecule adduct.

Figure 4.2 Chemical structures of common nitroxide spin labels (traps).
Note: TMPO = (3,3,5,5-tetramethyl-1-pyrroline-1-oxide), DMPO = (5,5-dimethyl-1-pyrroline N-oxide), and PBN = alpha-phenyl Ntertiary-butyl nitrone.
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4.3 Results and Disussion
4.3.1 Measurement of EPR spectra of benzoyloxy free radical (BPO• or PhCO2•)

Scheme 4.3 Formation of benzoyloxy radical (BPO•) by chemically reducing BPO with
hydrazine, followed by spin trapping with DMPO.
As shown in Scheme 4.3, BPO is reduced by hydrazine to (PhC(O)O)2- that
further decomposes to benzoyloxy radical (BPO•) and PhC(O)O-. Finally, BPO• reacts
with the spin trapping agent DMPO to form EPR active DMPO/BPO• adduct. The EPR
spectra of such a system is shown in Figure 4.3, where (a) is the experimentally obtained
spectra, and (b) is the simulation of (a). Considering the adduct structure (Scheme 4.3),
the unpaired electrode could couple with -N, -H (two possible conformation sites),293
and 2 -H.292 The simulated EPR spectra (Figure 4.3b) essentially matches the
experimental one. The simulated EPR spectra of hydroxyl radical (Figure 4.3c) does not
match the experimental one, especially the first peak at ~3485 G, suggesting that no
significant hydroxyl radical is formed under current experimental conditions. This is
easily understood, because in the reaction media, the initial concentration ratio of
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DMPO/BPO was 20, and newly produced BPO• free radicals were immediately caught by
DMPO, so that no free BPO• was left for water oxidation and OH• free radical
production.

Expt.

(a)

(b)

Simulation

(c)

DMPO/OH.

3460 3470 3480 3490 3500 3510 3520 3530 3540 3550 3560 3570

Magnetic Field (G)

Figure 4.3 EPR spectra of DMPO/•OOC6H5 adduct.
Note: 10.0 mM BPO was chemically reduced by 75.0 μM hydrazine and 200.0 mM DMPO was used as the spin trapping agent in
MeCN-H2O mixture media. The experimental parameters were: microwave power = 2.69 mW, resonant frequency = 19 GHz, Q value
= 8900, time constant = 20.48 ms, Modulation amplitude = 4 G. The EPR spectra was the average of 4 consecutive scans. For
simulation of spectra (b), a = 14.85 G, a = 10.00 G, aH’ = 8.80 G, aH1 = 2.15 G, and aH2 = 1.00 G were used. For simulation of
DMPO/OH• spectra shown in (c). aN = aH = 14.85 G were used.

Under UV irradiation, solid and solution phase benzoyloxy peroxide radicals are
produced as indicated in Equation 4.11.
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(PhC(O)O)2 + hv → (PhC(O)O)2* → 2(PhC(O)O•)

(4.11)

Figure 4.4A shows the EPR spectra from solid BPO without DMPO using UV
irradiation. Simulations of these spectra were found to be challenging and further
investigations are needed.
When solid BPO was mixed with a drop of 200 mM DMPO, and undertaken
irradiation of UV, the obtained EPR spectra (Figure 4.4B) were found to be very similar
to those resulted from the chemical reactions of BPO and hydrazine (Figure 4.3a),
confirming that the same radical (i.e., BPO•) was produced from the two-different means.
Again, in Figure 4.4B, DMPO/OH• adduct seems to be not present.
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Figure 4.4 EPR spectra obtained from (A) solid BPO without DMPO under UV
irradiation, and (B) solid BPO mixed with a drop of 200 mM DMPO solution under UV
irradiation.
Note: EPR experimental parameters were the same as in Figure 4.4.

4.3.2 Measurement of EPR spectra of sulfate anion radical (SO4•-)
Under UV irradiation, solid or solution phase persulfate forms sulfate anion
radical (SO4•-), which further reacts with the added DMPO to produce EPR active adduct
(Equations 4.12-13).
S2O82- + hv → (S2O82-) * → 2(SO4•-)

(4.12)

SO4•- + DMPO → DMPO/SO4•-

(4.13)

125

Persulfate anion radical can also be produced through chemical reactions between
persulfate and hydrazine (Equation 4.14).
S2O82- + N2H4 → S2O83- → SO42- + SO4•-

(4.14)

Figure 4.5A shows the EPR spectra of solid persulfate with DMPO under UV
irradiation and Figure 4.5B shows solution phase EPR spectra of persulfate in water with
hydrazine and DMPO in the absence of UV irradiation. Clearly, many more EPR signals
are present in the second case, which probably due to the existence of DMPO/OH• adduct
formed from the following reaction (Equation 4.15).325
SO4•- + OH- → SO42- + OH•

(4.15)
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Figure 4.5 EPR spectra of (A) solid persulfate with DMPO under UV irradiation, and (B)
persulfate in water with hydrazine and DMPO without UV irradiation.
Note: (A) EPR spectra were obtained with a resonant frequency of 9.87 GHz, a modulation frequency of 100 kHz, microwave power
of 9.93 mW. and time constant of 327.68 ms. The concentrations of ammonium persulfate and DMPO were 10 mM and 200 mM,
respectively. (B) EPR spectra were obtained with a resonant frequency of 9.87 GHz, attenuation 10 dB, a modulation frequency of
100 kHz, microwave power of 18.97 mW. and time constant of 20.48 ms. The concentrations of ammonium persulfate, hydrazine,
and DMPO were 10 mM, 75 µM, and 200 mM, respectively. The EPR spectra is the collection of 4 consecutive scans. The EPR
spectra is the collection of 4 consecutive scans.

4.4 Conclusion
The free radical intermediates of cathodic coreactants such as ammonium
persulfate and BPO generates sulfate anion radical (SO4•-) and benzoyloxy free radicals
(C6H5CO2• or BPO•) after electrochemical reduction of the coreactants in aqueous and
acetonitrile respectively. The direct EPR evidence of such free radical intermediates
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generated was mimicked by reducing these ECL coreactants chemically by hydrazine as
the reducing agent and DMPO as the spin trapping agent. Both DMPO (as spin trap) and
hydrazine (as reducing agent) respectively are needed to obtain the EPR spectrum
C6H5CO2• or BPO• in solution phase in MeCN solvent. Whereas neither the spin trap nor
the reducing agent are needed to obtain EPR spectrum of solid BPO which just needed
UV irradiation. The EPR spectra obtained from solid phase (with and without UV
irradiation) are very similar. For solution phase BPO in MeCN-H2O mixed solvent, it is
easy to tune the system in capillary tube rather than using the regular quartz EPR tube.
The EPR spectra of persulfate radical anion in aqueous medium using hydrazine as the
reducing agent and DMPO as the spin trapping agent as well as solid phase with UV
irradiation with DMPO spin trapping were collected and interpreted. For solution phase
persulfate in aqueous medium, it was easy to tune the system in capillary tube and could
not be tuned with a regular quartz EPR tube because aqueous solution can be heated by
the microwave resulting drift of the signals.
Some EPR spectra presented in this chapter need to be simulated so that identity
of the radicals can be confirmed.
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CHAPTER V – ULTRASENSITIVE ELECTROGENERATED
CHEMILUMINESCENCE BASED IMMUNOASSAYS FOR THE DETECTION OF
ZIKA AND DENGUE VIRUSES1
5.1 Introduction
Zika virus (ZIKV) is a member of the Flavivirus genus of the Flaviviridae family,
which includes other globally important pathogens, such as West Nile (WNV), dengue
(DENV), and yellow fever viruses.326,327 Recent outbreaks of ZIKV have linked this
previously neglected virus to the development of severe fetal abnormalities including
spontaneous abortion, stillbirth, microcephaly, and Guillain-Barré syndrome (GBS), a
neurological disorder.328 Autochthonous transmission of ZIKV infection has been
reported in Asia, Africa, Micronesia, and Latin America with increasing descriptions of
travel related cases worldwide.329-333 Since the Aedes species of mosquitoes that transmit
ZIKV circulate globally, there is a significant risk of ZIKV spread worldwide.334,335 Thus,
ZIKV is Organization estimated that as many as four million people could have be
infected in American countries in 2016.336 Currently, there is no approved therapy or
vaccine against ZIKV.
Dengue virus (DENV), on the other hand, is believed to be a leading cause of
illness and death in the tropics and subtropics, where about one-third of the world’s
population could be at risk for infection, as reported by the Centers for Disease Control
and Prevention. There are four serotypes of DENV (i.e., DENV1, DENV2, DENV3, and
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Diamond, M. S.; Miao, W.; Bai, F., An ultrasensitive electrogenerated chemiluminescence-based
immunoassay for specific detection of Zika virus. Sci. Rep. 2016, 6, 32227.
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DENV4), all of which are transmitted by mosquitoes and could cause up to 400 million
people infected each year. Unfortunately, no any vaccines to prevent infection with
DENV is currently available.
Similar to DENV, WNV and chikungunya virus (CHIKV), ZIKV infection in
humans can result in a range of clinical signs and symptoms including fever, rash, joint
pain, and conjunctivitis, which poses a challenge for differential diagnosis of these viral
infections as they often are co-transmitted in the same areas.337,338
In addition, ZIKV has been detected in semen, urine, and saliva,339-341 suggesting
a potential for transmission through routes other than mosquito bite, such as sexual
contact.342-344 Therefore, a highly sensitive and specific method for detection of ZIKV is
urgently needed to facilitate efficient case management, surveillance, and implementation
of control programs. Current methods for detection and diagnosis of ZIKV DENV
infections include nuclear acid-based assays, such as quantitative polymerase chain
reaction (qPCR), and antibody-based assays, such as enzyme-linked immunosorbent
assay (ELISA) or neutralization tests.345-347 Since the conventional nuclear acid-based
assays require expensive reagents and instruments, and ELISAs are time consuming and
have specificity concerns,348,349 a rapid and simple-to-use methodology with high
sensitivity, reliability, and cost effectiveness is needed.350,351
Electrogenerated chemiluminescence (ECL) is a phenomenon of light emission by
an excited state of species generated at electrodes that undergoes high-energetic electrontransfer reactions.113 The emitted light can be measured easily by simple
instrumentation,113,155 thus providing an efficient sensor for rapid and simple-to-use
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devices for separation, detection, and quantification of a diverse range of analytes in a
small quantity (up to femtomolar scale) of starting sample. Applications of ECL-based
detection have been demonstrated successfully in a wide range of immunological and
molecular assay systems including clinical diagnosis,155,163,352 biosensing,353-355 drug
assays,356 food quality analysis,357,358 environmental monitoring,161,359 and forensic
chemistry.360-362 Several strategies have been developed to optimize and amplify ECL
detection signals. For example, it has been previously reported that the polystyrene beads
(PSBs) could be loaded with several billions of water-insoluble homemade
Ru(bpy)3[B(C6F5)4]2 (bpy = 2,2'-bipyridine) ECL labels. This step increased the ratio of
ECL label to bioanalyte and amplified ECL signals by several order of magnitudes.155,156
By conjugating ECL label-loaded PSBs with specific antibody or antigen, a highly
sensitive detection platform of diverse repertoire of analytes can be achieved.
In this chapter, highly sensitive and specific ECL-based immunoassays for
detection and quantification of ZIKV and DENV4 in biological fluids with a limit of
detection of 1 plaque-forming unit (PFU) in 100 μL of samples are reported. The rubrene
(RUB)/benzoyl peroxide (BPO) system will be our choice of sensing, because it showed
the most efficient ECL emissions in MeCN as described in Chapter II. This study
provides an essential proof-of-concept that ECL-based immunoassays can be developed
for the detection and quantification of viruses.
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5.2 Experimental
5.2.1 Chemicals and reagents
Monoclonal antibody (mAb) against ZIKV (ZV2, IgG2c) specifically recognizes
the E protein on ZIKV and was generated after immunization of mice with infectious
ZIKV.363 Mouse mAb specific to flaviviruses (4G2) was produced and purified by
culturing hybridoma (HB-112, ATCC) as previously described.364 Carboxylate
polystyrene beads (referred as PSB, 10 μm diameter, 2.6% (w/w) aqueous suspension
with approximately 6.5 × 104 beads μL-1) and streptavidin-coated super-paramagnetic
polystyrene beads (referred as MB, 1.0 μm diameter, 10 mg mL-1 aqueous suspension
with approximately 9.5 × 106 beads μL-1) were purchased from PolySciences Inc. and
Dynal Biotech Inc., respectively. Other reagents were purchased from either Sigma or
other commercial vendors.
5.2.2 Preparation and titration of virus stocks
A recent strain of ZIKV (PRVABC59) was obtained from B. Johnson (CDC
Arbovirus Branch, Fort Collins CO). CHIKV (LR-OPY1-2006 strain) was provided by R.
Tesh (University of Texas Medical Branch). WNV isolate (CT2741) and the four
serotypes of dengue viruses (DENV1, DENV2, DENV3, and DENV4) were provided by
J. Anderson (Connecticut Agricultural Experiment Station). WNV, ZIKV, and CHIKV
were propagated in African green monkey kidney cells (Vero cells, ATCC CCL-81) and
DENV (DENV1, DENV2, DENV3 and DENV4) were propagated in C6/36 Aedes
albopictus cells. All virus stocks were titered in Vero cells (ATCC CCL-81) by plaque
assay as previously described.365
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5.2.3 ECL label loading and avidin conjugation of PSBs.
Loading of ECL-labels to PSBs was performed as previously described 113,156 with
some modifications. Briefly, carboxylated PSBs were loaded with RUB by immersing the
beads into a saturated solution of RUB (∼0.7 mM) in 5% benzene–95% MeOH (v/v) for
2 h, followed by a series of centrifugation, washing, and drying. Prepared PSBs were
designated as PSB(RUB). For avidin conjugation, the PSB(RUB) beads were reacted
with a freshly prepared avidin solution (25 μM), activated in a 1-methylimidazole-HCl
buffer (0.10 M, pH 7.2) containing 0.10 M EDAC and 0.10 M NHS for 1h, followed by
centrifugation, washing and re-suspension in PBS buffer (pH 7.2). The final solution
containing approximately 6.5 × 104 μL-1 of avidin conjugated PSB(RUB) beads was
stored at 4 °C until use.
5.2.4 Attachment of biotinylated antibodies to the surface of ECL-label loaded PSBs
and MBs.
Biotinylation of antibody was performed as described.155 Biotinylated antibody
was immobilized on the surface of ECL-label loaded PSBs by mixing 400 μL of avidincoated beads with 1.5 mL of biotinylated antibody (0.05 mg/ml) and rotating the mixture
in a Dynal sample mixer at 20 rpm for 1 h. Free antibodies then were removed from the
newly formed mAb-PSB(RUB) conjugates by washing four times with PBS and
conjugates were re-suspended in 400 μL of PBS (pH 7.2). Likewise, freshly washed MBs
corresponding to 100 μL of the original MBs suspension was immersed in 1.5 mL of
0.05 mg/mL of biotinylated antibody, and the mixture was then rotated with a Dynal
sample mixer at 20 rpm for 1 h. Newly formed mAb-MB conjugates were separated from
the solution mixture with a magnet (Dynal MPC-S), followed by washing and re133

suspension in 100 μL of PBS buffer (pH 7.2). The resulting mAb-MB and mAbPSB(RUB) conjugates were stored at 4°C until use.
5.2.5 ECL and electrochemical measurements
To measure ECL-intensity, aggregates were dissolved in a 2.0 mL solution of
10.0 mM BPO-0.10 M TBAP in MeCN for optimized ECL measurements (see results for
details). A three-electrode system with a 2.0-mm diameter Pt disk as the working
electrode, a Pt wire as the counter electrode, and a Ag/Ag+ (10 mM AgNO3 and 0.10 M
TBAP in MeCN) as the reference electrode were used. All three electrodes were
incorporated in a 5-mL disposable glass vial cell containing assay samples. Before each
measurement, the Pt electrode was polished with a 0.3 μm alumina slurry, and all
electrodes were cleaned carefully by washing with excess water followed by rinsing with
MeCN. The ECL intensities along with the cyclic voltammetry signals (CV) were
recorded simultaneously in a home-built ECL instrument as described previously.161 This
instrument consists of a 660A electrochemical workstation (CH Instruments, Austin, TX,
USA) combined with a photomultiplier tube (PMT, Hamamatsu R928, Japan) installed
under the electrochemical cell. A voltage of −700 V was supplied to the PMT with a high
voltage power supply (Model 472A Brandenburg PMT power supply, England). The
light signal (as photocurrent) was detected with a high sensitive Keithley 6514
electrometer (Keithley, Cleveland, OH, USA) and converted to voltage (in ±2 V) that was
collected to the electrochemical workstation computer. Unlike the commercially available
BioVeris ECL system, where flow-cell based ECL detection is used; our ECL instrument
uses conventional electrochemical cells. For cathodic ECL measurements, the testing
solutions were pre-degassed with ultra-high purity of nitrogen (Airgas South,
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Hattiesburg, MS) for 7-10 min. All measurements were conducted at a temperature of
23 ± 2°C.
5.2.6 Confocal Microscopy
ECL label loaded PSBs and PSB-virus-MB aggregates were imaged in a Zeiss
LSM510 META confocal microscope (Carl Zeiss, NY).
5.2.7 Transmission Electron Microscopy
Transmission electron microscopy (TEM) images were obtained using a JEOL
2100 transmission microscope operating at 200 kV. TEM images of ZIKV, PSB, and
PSB<ZIKV>MB were obtained using copper mesh grids with Formvar support film.
5.2.8 Real time-quantitative PCR (RT-qPCR)
ZIKV particles attached on the surface of beads (i.e., PSB<ZIKV>MB) were
quantified by RT-qPCR, as described previously.365 Briefly, PSB<ZIKV>MB complexes
prepared with different concentrations of ZIKV were treated with TRI-reagent
(Molecular Research Center) to lyse viral particles, and viral RNA was isolated after
adding 1 μg of tRNA (ThermoFisher Scientific) as carrier. The complementary DNA
(cDNA) was synthesized using the iSCRIPT cDNA synthesis kit (Bio-Rad) and RTqPCR assays were performed in a CFX96 Real-Time system (Bio-Rad) using iTaq
universal probe supermix (Bio-Rad). Primers (Forward,
GGAGTCAGCAATAGGGACTTTG; Reverse, CGGTTTGTCCTGTGCCATTA) and
probe (FAM/AGGTGGGAC/ZEN/TTGGGTTGATGTTGT/3IABkFQ) specific to the
Envelope gene of ZIKV were designed and synthesized by Integrated DNA
Technologies.
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5.2.9 Western blotting
Antibody conjugation to beads was analyzed by immunoblotting as previously
described.365 Briefly, the beads were treated with Laemmli sample buffer (Bio-Rad) and
proteins were separated by 10% SDS-polyacrylamide gel electrophoresis, followed by
transfer to a nitrocellulose membrane (Bio-Rad). Heavy chain and light chain of antibody
were detected by probing the membrane with horseradish peroxidase conjugated goat
anti-mouse IgG antibody (Jackson Immunoresearch). Images were acquired in a
ChemiDoc MP system (Bio-Rad) by using SuperSignal West Pico Chemiluminiscence
Substrate (Thermo Scientific).
5.3 Results
5.3.1 Assay design, ECL-label loading and antibody conjugation of polystyrene and
magnetic beads
A scheme of the ECL-based strategy for detection of viruses is shown in Figure
5.1A, which is developed based on previous studies 155,156,161 with a more sensitive
RUB/BPO sensing system. Briefly, the loading of ECL-labels (e.g., RUB) to PSBs
amplifies the signal intensity several orders of magnitudes, generating a highly sensitive
detection system. Subsequent conjugation of ECL label loaded PSBs with virus-specific
antibody allow specific binding of virus particles to the PSBs surface. By using magnetic
beads (MBs) conjugated with virus-specific antibody as a capture element, virus bound to
ECL-label loaded PSBs can be separated magnetically and subjected to measurement of
ECL-intensity after the dissolution of the PSB<virus>MB aggregates in MeCN, the latter
signal is proportional to the amount of virus present in the samples. To develop a specific
and highly sensitive ECL-based immunoassay for detection of ZIKV, PSBs were loaded
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with RUB by immersing the beads into a saturated solution of RUB. These PSBs,
designated as PSB(RUB), had a typical loading capacity of ∼3.3×109 RUB molecules per
bead, which was estimated on the basis of the ECL data obtained from the PSB(RUB)
dissolved in MeCN and a set of standard RUB solutions using BPO as a coreactant. ECL
label loading of PSBs with RUB was confirmed with a fluorescence microscope, which
shows that PSB(RUB) beads glow as intense yellow color when exposed to UV light
(Figure 5.1B). No such signal was detected from unloaded (bare) PSBs (data not shown).
Subsequently, avidin was covalently attached to the surface of the PSB(RUB) beads via
amide bonding. Avidin conjugated PSB(RUB) beads then were mixed with a biotinylated
monoclonal antibody (mAb ZV-2) that is specific to ZIKV and does not recognized
closely related flaviviruses, including DENV (data not shown). This step generated an
antibody-conjugated PSB(RUB) (abbreviated as anti-ZIKV-PSB in following text) for
specific detection of ZIKV. In addition, magnetic beads (MBs) were conjugated with ZV2 mAb through biotin-streptavidin conjugation (anti-ZIKV-MB), which can serve as a
capture element for magnetically separating ZIKV bound to PSB(RUB) in subsequent
ECL-intensity measurements. Conjugation of ZV-2 to PSB (Figure 5.1C, left) and MB
(Figure 5.1C, right) was confirmed by Western blotting. The ECL behavior of antiZIKV-PSB complexes were studied. These complexes exhibited a stable and consistent
ECL response similar to those shown in Figure 5.1C for RUB/BPO solutions, suggesting
no alteration in ECL behavior of RUB after loading to PSB and antibody conjugation.
Taken together, these data suggest that the anti-ZIKV-PSB complexes serve as both
target binding reagent and ECL signal generator, and are suitable to capture ZIKV from
solution.
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Figure 5.1 Assay design and preparation of immuno-conjugated and ECL-loaded beads.
Note: (A) Cartoon representation of fabrication of immunosensor for ZIKV and DENV4 (B) Image of rubrene loaded PSBs (golden
yellow, right) taken under UV-light (385 nm excitation) in a confocal microscope. (C) Antibody conjugation to PSBs and MBs was
analyzed by immunoblotting assay. Note: All experiments were performed in duplicates and repeated at least one time.

5.3.2 Anti-ZIKV-PSB capture of ZIKV
To test whether anti-ZIKV-PSB can capture ZIKV, 104 PFU of ZIKV (strain
PRVABC59) in 0.1 M PBS (pH 7.4, 100 μL) containing 2% BSA were incubated with
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anti-ZIKV-PSB (40 μL) for 45 min in a Dynal mixer to form ZIKV-anti-ZIKV-PSB
complexes. These complexes were washed twice (8,000 g, 3 min) with PBS, resuspended in 100 μL PBS containing 2% BSA, then reacted with 10 μL of capture
element (anti-ZIKV-MBs) for 45 min in a Dynal mixer form PSB<ZIKV>MB
aggregates, which were separated by using Dynal magnetic separator. After
centrifugation, some of the PSBs in the control samples (without virus) attach on the wall
of the microfuge tube. In comparison, after addition of viruses followed by
centrifugation, the virus-PSB complexes settled down at the bottom of microfuge tube
(Figure 5.2A), indicating that the ZIKV causes aggregation of anti-ZIKV-PSBs. In
addition, after magnetic separation, the beads that bound the PSBs can be observed in the
wall of tube (Figure 5.2B), suggesting the formation of PSB<ZIKV>MB aggregates in
the presence of ZIKV. As shown in a micrograph (Figure 5.2C), anti-ZIKV-PSB
complexes undergo aggregation in the presence of ZIKV and anti-ZIKV-MBs. To detect
and quantify the ZIKV bound to PSB<ZIKV>MB aggregates, different amounts of ZIKV
(0 to 104 PFU) were used to form aggregates, which were separated magnetically and
subjected to extraction and RT-qPCR analysis of ZIKV RNA. The PCR results confirmed
that ZIKV bound to PSB<ZIKV>MB aggregates validating the efficiency of ECL-based
assay to capture ZIKV (Figure 5.2D). Collectively, these results suggest that conjugation
to ECL label loaded PSBs does not alter the specificity of anti-ZIKV antibody,
suggesting that this system can be used to selectively capture the target ZIKV particles.
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Figure 5.2 Immuno-conjugated and ECL label loaded polystyrene beads capture ZIKV.
Note: (A) Photograph of a microfuge tubes after addition of ZIKV containing samples to ZV2-PSB(RUB), showing the aggregation of
PSBs at the bottom of tube in the presence of ZIKV. (B) Photograph of a microfuge tubes after magnetic separation showing (arrow)
the free MBs (right), and binding of PSBs to MBs (left) in the presence of ZIKV. (C) A phase-contrast image of
PSB<ZIKV>MBaggregates showing the binding of anti-ZV2-MB (1 μm diameter, arrow) to the surface of anti-ZV2-PSB (10 μm
diameter) in the presence of ZIKV. (D) PSB<ZIKV>MB aggregates that were obtained from samples containing different PFUs of
ZIKV were analyzed by RT-qPCR assay to quantify copy number of ZIKV envelope gene. All experiments were performed in
duplicates and repeated at least one time.

Figure 5.3 shows TEM images during detection of ZIKV. More specifically,
Figure 5.3 (A) shows white illumination of ZIKV under negative stain of
phosphotungstic acid, indicating the ZIKV viral particle size was 40 nm. Figure 5.3 (B)
shows only PSBs that are loaded with rubrene and coated with neutravidin, designated as
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PSB(RUB)|avidin. Figure 5.3 (C) shows PSB<ZIKV>MB final aggregates showing many
MBs attached to a PSB, and Figure 5.3 (D) is the zoomed image of PSB<ZIKV>MB final
aggregate showing only one MB.

Figure 5.3 TEM images during detection of ZIKV.
Note: (A) white illumination of ZIKV under negative stain of phosphotungstic acid, (B) PSB(RUB)|avidin, (C) PSB<ZIKV>MB final
aggregates showing many MBs attached to a PSB, and (D) zoomed image of PSB<ZIKV>MB final aggregate showing only one MB.

5.3.3 Anti-ZIKV-PSB specifically detects ZIKV in a highly sensitive manner
To detect ZIKV, anti-ZIKV-PSBs were mixed with different amounts of ZIKV (0
to 104 PFU) diluted in PBS with 2% BSA. The resulting virus-PSB conjugates were
washed to remove unbound viruses and re-suspended. Virus-PSB conjugates then were
allowed to react with the capture element (i.e., anti-ZIKV-MB) to form sandwich-type
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PSB<ZIKV>MB aggregates, which were magnetically separated from the reaction
medium. PSBs that did not have bound viruses do not form aggregates and remain in
solution during magnetic separation. Thus the ECL-intensity obtained from the
PSB<ZIKV>MB aggregate is proportional to the concentration of virus in a sample.
Figure 5.4A shows that the ECL intensity of the purified MB-ZIKV-PSB aggregates
increase with the amount of virus in the samples. Notably, the ECL response obtained
from sample containing 1 PFU of ZIKV is distinguishable from the background (i.e., no
virus in the system), indicating that the present detection platform has a detection limit of
as low as 1 PFU, which is comparable to RT-PCR (see Figure 5.2D). If the concentration
of virus in a sample is low, the amount of PSB-virus-MB species formed should be also
low. In this case, most of the ECL-signal remains in free (virus-unbound) PSBs that are
left in solution during magnetic separation. To confirm these results, the ECL intensity of
virus-free PSBs was measured, which was expected to be complementary with the ECL
signals obtained from PSB-virus-MB aggregates. Indeed, the ECL signals from the virusunbound PSBs displayed an inversed relationship with the original amount of ZIKV
added to samples (Figure 5.4B). This was expected, because each sample used the same
amount of PSBs; the more PSB<ZIKV>MB aggregates are formed, the less PSBs remain
in the solution. These results also show that there is no loss of ECL-intensity during the
assay, confirming that the ECL-intensity of PSB-virus-MB is proportional to the amount
of complex formed, hence the amount of virus present in the samples. To analyze further
the relationship between ECL-intensity and the amount of virus in the samples, area
under the ECL-curves were calculated and plotted the average values against the amount
of virus added to the samples. The results showed a linear relationship between the virus
142

amount and the ECL-intensity of PSB<ZIKV>MB aggregates as well as free PSBs in the
supernatant (Figure 5.4C). These results suggest that the ECL-intensity proportionally
reflects the amount of viral particles present in samples in a sensitive manner.
To determine whether anti-ZIKV-PSB specifically binds to ZIKV, unrelated
(chikungunya virus (CHIKV)) or related (West Nile virus (WNV) and dengue (DENV,
serotype 1-4)) mosquito-transmitted viruses were tested with the developed ECL-based
immunoassay. As shown in Figure 5.4D, the ECL-intensity of samples containing 103
PFU of CHIKV, WNV, or DENV has a substantially lower ECL signal as compared to
ZIKV. The inset of Figure 5.4D illustrates the normalized ECL intensity of six viruses
compared to ZIKV, and suggests that the detection of ZIKV by an anti-ZIKV-PSB based
immunoassay has an acceptable selectivity of ~90%. In addition, ECL label loaded PSBs
and MBs were conjugated with a mAb (4G2) that binds to the conserved fusion loop
epitope of the E protein of most flaviviruses.366 The stability of the ECL-based
immunoassay based on PSB<ZIKV>MB system is actually determined by the stability of
the RUB/BPO ECL system, because trace amounts of PSB and MB debris as well as biosubstances present in MeCN solution do not interfere the ECL generation. Stable and
reproducible ECL signals were observed from the same test solution over different
potential cycles and on different testing days.
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Figure 5.4 Anti-ZIKV-PSB specifically detects ZIKV in a highly sensitive manner.
Note: Samples containing different amounts of ZIKV (0-104 PFU) were prepared in PBS containing 2% BSA and allowed to form
PSB<ZIKV>MB complexes by reacting with ZV2-PSB(RUB) and ZV2-MB. PSB<ZIKV>MB complexes were separated
magnetically and subjected to ECL-intensity measurement. (A) ECL-response curves of PSB<ZIKV>MB aggregates obtained from
samples containing different PFUs of ZIKV in PBS. (B) ECL-response of free (unliganded) PSB(RUB) that remained in solution after
magnetic separation. (C) A calibration curve of mean ECL intensity of magnetically separated PSB<ZIKV>MB aggregates (upward
line, black) and free PSB(RUB) (downward line, blue) that remained in solution after magnetic separation. (D) ECL response of
PSB<ZIKV>MB aggregates obtained from samples containing related (DENV and WNV) or unrelated (CHIKV) viruses (10 3 PFU)
prepared in PBS containing 2% BSA. Sample containing no virus was used as a control to determine background signal (~0, see
Figure 5.4C). All experiments were performed in duplicates and repeated at least one time.

5.3.4 ECL-based immunoassay can detect ZIKV in human biological fluids
ZIKV is present in human blood, urine and other body fluids.339,340,367 To test
whether our ECL-based immunoassay can detect ZIKV in human body fluids, we
collected plasma and urine specimens from healthy human volunteers and spiked in
different amount of ZIKV. In these samples, we performed ECL-based immunoassay and
measured the ECL-intensity of PSB<ZIKV>MB aggregates. Consistent with the results
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obtained in PBS, our ECL-based assay detected as few as 1 PFU of ZIKV in 100 µL of
human urine (Figure 5.5A) and plasma (Figure 5.5B). These results were complemented
by measuring the ECL intensity of virus-free PSBs that remain in solution after magnetic
separations (Figures 5.5C and 5 5D), which show a progressive decrease of ECLintensity with increasing amount of ZIKV present in samples. The area under the ECL
curves were plotted against amount of PFUs added to the samples (Figures 5.5E and
5.5F) and produced a linear curve, suggesting that the ECL-intensity of the PSB-virusMB aggregates formed is proportional to the amount of ZIKV in the sample. These
results establish that the ECL-based immunoassay can detect ZIKV in clinical samples in
an ultrasensitive and specific manner.
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Figure 5.5 ECL-based immunoassay detects ZIKV in human biofluids.
Note: Samples containing different amounts of ZIKV (0-103 PFU) were prepared in human urine or plasma specimens collected from
healthy human volunteers. ECL-response from PSB<ZIKV>MB aggregates obtained from (A) plasma, and (B) urine samples
containing different PFUs of ZIKV. ECL-response of virus-free PSB(RUB) that remained in solution after magnetic separation from
(C) urine and (D) plasma samples. A calibration curve of mean ECL intensity of magnetically separated PSB<ZIKV>MB aggregates
(upward line, black) and free PSB(RUB) (downward line,blue) that remained in solution after magnetic separation were generated
from (E) urine and (F) plasma samples. No virus control was used to determine background signal. All the experiments were
performed in duplicates and repeated at least one time.

5.3.5 ECL Detection of DENV4
For the detection of DENV4, similar strategy to the ZIKV detection as described
above was used, where the experimental conditions and the procedures remained the
same but the antibody was changed to anti-4G2 that detects most of the flaviviruses.
Experimentally, the samples containing different amounts (0-104 PFU) of DENV4 in PBS
containing 2% BSA were allowed to form PSB<DENV4>MB aggregates by reacting
with anti-4G2-PSB(RUB) and anti-4G2-MB. The final PSB<DENV4>MB aggregates
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were dissolved with 2.0 mL of 10.0 mM BPO followed by ECL measurements after
degassing with N2.
Figure 5.6 shows the photographs of centrifuge tubes at different stages of
DENV4 detection. More specifically, Figure 5.6A shows the PSB-DENV4 conjugates
before MB separation, where large numbers of DENV4 correspond to more precipitates
of PSB-DENV4 conjugates at the bottom of the tube. Figure 5.6B shows that the spot
size of PSB<DENV4>MB aggregates on the wall of the tube progressively decreases
with the decrease of DENV4 concentration. This is expected, because the less numbers of
DENV4 are, the less conjugates of PSB-DENV4 are formed, and the less numbers of
PSB<DENV4>MB aggregates can be collected. Consistent with the above observations,
the number of free unbound PSB(RUB) beads collected from the supernatant increase
with the decrease of DENV4 concentration as illustrated in Figure 5.6C.
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Figure 5.6 (A) PSB(RUB)-anti-4G2 conjugates, (B) PSB(RUB)<DENV4>MB final
aggregates and (C) Free (unbound) PSB(RUB) from the supernatant.
The final aggregates of PSB<DENV4>MB shown in Figure 5.6B were dissolved
in 2.0 mL of 10.0 mM BPO and subjected to ECL measurements. Figure 5.7A shows the
ECL-potential profiles of solutions associated with different concentrations of DENV4,
where progressive increase of ECL signal along with the increase of DENV4
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concentration is generally seen. Figure 5.7B displays the linear relationship between the
integrated ECL intensity and the logarithmic concentration of DENV4, where the upward
line is obtained from the solution containing dissolved PSB<DENV4>MB aggregates,
and the downward line corresponds to the solution containing dissolved free PSB(RUB)
that remained in solution after magnetic separation. Because a constant number of
PSB(RUB) was used for each DENV4 test, an opposite ECL intensity change is expected
from the test solution associated with PSB<DENV4>MB aggregates and free PSB(RUB)
beads. Notably, the ECL signal of 1 PFU DENV4 can be clearly distinguished from the
background, indicating a limit of detection of 1 PFU/100 mL DENV4 with the present
ECL method.
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Figure 5.7 ECL-responses from PSB-DENV4-MB aggregates obtained from samples
containing different concentrations of DENV4 viruses.
Note: (A) Samples containing different amounts (0-104 PFU) of DENV4 in PBS containing 2% BSA were allowed to form PSBDENV4-MB aggregates by reacting with anti-4G2-PSB(RUB) and anti-4G2-MB. All the experiments were performed in duplicates
and repeated at least one time. (B) Plot of a calibration curve of mean ECL intensity of magnetically separated PSB<DENV4>MB
aggregates (upward line, black) and free PSB(RUB) (downward line, blue) that remained in solution after magnetic separation were
generated in PBS buffer.

5.4 Discussion
Mosquito transmitted viruses, such as DENV, Japanese encephalitis virus, and
WNV are worldwide public health challenges.368 Recent emergence of CHIKV 369 and
ZIKV 370,371 has prompted a global public health emergency. Besides mosquito
transmission, these viruses also can be transmitted through other routes, such as blood
transfusion, organ transplantation, and in utero.372,373 For instance, ZIKV virions or RNA
can be detected in semen, urine, and saliva, and is categorized as a high-priority
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infectious agent with the risk of sexual-transmission.342-344 Importantly, there is no
approved vaccine or specific therapy against the most of these mosquito-transmitted
viruses. Early and accurate diagnosis of viral infection can reduce the risk of severe
consequences, such as DENV hemorrhagic fever, shock syndrome and ZIKV-related
developmental defects. Most of the currently available diagnostic methods for viral
infection are based on detection of viral antigens, antiviral antibodies, or viral nucleic
acid. Although the nucleic acid-based methods are sensitive, they require expensive
reagents and instruments. For immunoassays, the performance is often poor due to crossreactivity with other flaviviruses (e.g. Dengue) and difficulty in clinical correlation.
Direct detection of viruses is challenged by requirement of facilities, such as cell culture
or electron microscopy, which are not available in most diagnostic laboratories. Thus, a
rapid, simple-to-use, sensitive, and cost-effective assay for virus detection in clinical
specimen is highly desirable.
An ECL-based detection assay may be ideal for virus detection as it offers several
advantages including ultrasensitivity, reproducibility, cost-effectiveness, and rapidness
over conventional immunoassays and PCR-based assay,85,374,375 as demonstrated in this
chapter for detection of ZIKV and DENV4 in human biological fluids. Moreover, as
ZIKV has been suggested to be transmitted by blood transfusion, the ECL-based assay
could be developed for blood screening of ZIKV. By utilizing various ECL-emitters
(such as RUB, Ru(bpy)32+, and DPA) that have easily distinguishable excitation and
emission properties,376 ECL-based immunoassays have multiplexing capacity for
simultaneous detection of several types of viruses in a single sample.
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5.5 Conclusion
Ultrasensitive ECL based immunoassays were fabricated for sensitive and
specific detection of zika virus (ZIKV) and dengue virus (DENV4) in human body fluids.
As low as 1 PFU/100 μL or 10 PFU/mL of ZIKV and DENV4 were detected using
sensitive RUB/BPO ECL system in MeCN. This was achieved by amplifying the ECL
signal using two particles (beads) assay using polystyrene bead as ECL label carrier
whereas magnetic bead as conjugates or aggregates separation moderator. This proof-ofconcept study can be extended to the detection of other viruses or pathogens.
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CHAPTER VI – CONCLUDING REMARKS

Electrogenerated chemiluminescence (ECL) is a process of light emission at the
surface of the working electrode resulting from electrochemical and chemical reactions of
the ECL emitters (labels) with or without the use of deliberately added ECL coreactants.
ECL is electrode potential controlled. ECL is “on” when potential is applied and ECL is
“off” once the potential is disconnected. For the process of ECL to be relatively efficient
or ECL to be strong (ECL intensity in the scale of microampere range scale when
micromolar concentrations of ECL emitters are used), the electrogenerated emitter
radicals must be sufficiently stable in the reaction media. The highly efficient ECL could
be produced by adding coreactants that allow the ECL process to occur upon either
anodic potential scanning or cathodic scanning. ECL can be detected by using various
light detectors coupled with or without wavelength selectors including photomultiplier
tube (PMT), charge coupled devices (CCDs), and complementary metal–oxide–
semiconductor (CMOS). Thus, ECL can also be understood as a marriage between
electrochemistry and spectroscopy. Most diagnostic methods are often challenged by
three factors—sensitivity, selectivity and stability of the biosensor. ECL based biosensors
are promising when addressing these issues.
After an introduction chapter of the dissertation (Chapter I), systematic ECL
studies of unmixed and mixed systems of three most efficient ECL emitters, namely,
9,10-diphenylanthracene (DPA), rubrene (RUB), and tris(2,2'-bipyridine)ruthenium(II)
complex (Ru(bpy)32+), using benzoyl peroxide (BPO) as a common cathodic coreactant
and 2-(dibultylamino)ethanol (DBAE) or tri-n-propylamine (TPrA) as an anodic
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coreactant in acetonitrile, were studied for their potential applications in multiplexing
ECL detection of multiple target analytes (Chapter II). The experiments were performed
with a homemade, portable, and inexpensive spectral ECL instrument. The search for
most favorable coreactant turned out to be the cathodic coreactant BPO among tested
coreactants of DBAE, TPrA, and BPO. Certain interactions associated with energy
transfer were observed when different ECL emitters were mixed in the same system,
which was confirmed by fluorescence titrations and consistent with their emission and
absorption spectra. The experiments and spectral ECL instrument can be well-adapted by
college level chemistry laboratories especially senior undergraduate analytical chemistry
and instrumental analysis courses.
In Chapter III, an extension of the study done from Chapter II was explored.
Synthesis, electrochemistry, and ECL studies of water soluble analogues of DPA and
RUB were carried out. Different ECL coreactants and electrode materials on the ECL
behavior of sulfonated DPA (DPAS), sulfonated RUB (SRUB), and Ru(bpy)32+ were
systematically examined. DBAE and Pt electrode were found to be most favorable
coreactant and electrode, respectively. The relatively weak ECL responses can be
remarkably enhanced by adding 10.0 mM nitrate salt to the ECL system. The proposed
mechanism involving the production of NO3• free radicals, which chemically reacted with
ECL emitter and coreactant to form species crucial for ECL production. Electron spin
resonance spectroscopy (EPR) experiments with solution phase KNO3 mixed with spin
trapping agent DMPO under UV irradiation provided direct evidence of the existence of
such a free radical. ECL titration studies of mixed systems of the emitters using DBAE
and nitrate salt were also carried out.
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In Chapter IV, EPR studies of radical intermediates (C6H5COO• and SO4•-) of
cathodic ECL coreactants benzoyl peroxide (BPO) and persulphate salt were presented.
Several strategies were used for the generation of radicals, which included solid and
solution phase coreactant with and without DMPO under UV irradiation and chemical
reductions of coreactants with hydrazine. These data provided direct evidence that
supports various ECL mechanisms proposed previously, although detailed explanation or
interpretation of such EPR spectra are yet to be done.
In Chapter V, sensitive and selective detection of viruses, namely zika virus
(ZIKV) and dengue virus (DENV4) was reported using two particles (beads) based ECL
immunoassay, where polystyrene bead was used as ECL label carrier and magnetic bead
as conjugate or aggregate separation moderator. The loading of ECL label rubrene inside
the polystyrene allowed huge amplifications resulting in sensitive detection of viruses
(DENV4 and ZIKV) with a LOD of 10 plague forming unit (PFU)/mL or 1 PFU/100 μL
sample.
One of the important future direction of the studies can lead to the application of
the studied multiple efficient emitters and coreactants for multiplexed assays for
detecting multiple analytes simultaneously. For example, using two efficient ECL
emitters DPA and RUB with effective combination of cathodic ECL coreactant BPO
could generate ECL at two distinct emission wavelengths of ~420 nm and ~550 nm,
respectively, for the detection of two analytes of interest simultaneously without preseparation.
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